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Cigarette smoking is the leading preventable cause of death globally. Smoking, in addition to 
causing multiple diseases, increases the risk of cancers, COPD and heart disease to list a few. 
Nicotine also accounts for the addictive properties of cigarette smoking. Withdrawal symptoms 
experienced during a quit attempt are often the reason why smokers seek help in the form of 
conventional and/or complementary therapies. These symptoms include headaches, depression, 
anxiety, insomnia and coughing. 
 
The aim of this study was to determine the use of various CMs in the cessation of cigarette smoking 
in Johannesburg, SA, by surveying smokers and former smokers.  
 
This online survey included 122 participants who were recruited via email from various 
corporations. The data of this descriptive and quantitative study was collected and analyzed by 
means of Chi-squared test independence and cross-tabulations of selected and specific data. Likert-
scale questions and custom tables were used.  
 
The majority of participants 54 (44,2%) stated that they had smoked for 0-10 years, with 34 
(27,9%) participants smoking 11-15 cigarettes daily. Results demonstrated that 97 (79,5%) 
participants were extremely aware of the health risks posed by cigarette smoking. On average, 
participants made between 1 and 5 quit attempts, resulting in abstinence periods of months for 36 
(35,3%) of the participants, most commonly. The higher the level of nicotine dependence, the 
more quit attempts were made by smokers. Results demonstrated that smokers of an older age tend 
to smoke more cigarettes daily. The reasons why participants wanted to stop or reduce smoking 
were most commonly for health reasons and for loved ones. Relapses during quit attempts were 
said to be due to association with smokers, stress, mood swings and struggling to cope with 
emotions. Willpower was the most influential cessation method used, while homeopathy was the 
most used and most effective CM used in cessation.  
 
The symptoms included in a smoking quit attempt and those experienced in mental health disorders 
show vast similarities. Coping mechanisms and lifestyle adjustments are needed to assist people 
in coping with stressors which frequently lead to cigarette smoking. The use of CM in smoking 
cessation is not utilized to a large extent due to a lack of sufficient knowledge in CM. For this to 
be expanded, research on effective of CM therapies in smoking should be improved and education 
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1.1 Problem statement 
Cigarette smoking is the leading preventable cause of death globally (CDC, 2013). Tobacco in the 
form of cigarettes is composed of many chemicals, some naturally occurring, while others are 
synthetic and added during the manufacturing process. Nicotine, which is the primary addictive 
element of cigarettes, is one of the natural components and is the active ingredient in tobacco. 
Smoking-related illnesses including cancers, heart disease and stroke are only a few which 
contribute to the current death rates (Zyl-Smit, 2013). The health risks caused by smoking increase 
the death rate to twice that of non-smokers and former smokers. Cigarette smoking has a large and 
negative impact on the health of the smoker and those around them, in addition to the environment, 
society and the economy (Perucic, 2016).  
 
People start smoking for various reasons including stress, anxiety and social acceptance, which is 
especially seen in younger smokers. Many smokers want to quit, however, only a small portion 
achieve long-term abstinence. Various methods and therapies are used during quit attempts, to try 
and achieve cessation success. Little is known about smoking cessation and what it takes to achieve 
successful cessation and long-term abstinence. Complementary Medicine (CM) “refers to a broad 
set of health care practices that are not part of that country’s tradition or conventional medicine and 
are not fully integrated into the dominant health-care system” (Gower, 2017). Knowledge regarding 
CM use, specifically in cigarette smoking cessation is unfortunately insufficient and thus calls for 
an investigation.  
 
Research shows that smokers use CM, among other conventional methods to aid in quitting 
smoking. Education on CM is crucial in ensuring safe and effective practices, being provided to 
smokers once they have decided to quit. CM includes acupuncture, herbal medicine and 
homeopathy, to name a few. These therapies have been used in the treatment of withdrawal 
symptoms experienced during a smoking quit attempt, as well as the illnesses caused by smoking 
(Cain, 2015).  
 
A large percentage of smokers who make quit attempts relapse several times, leading to multiple 
attempts being made by many of the smokers, despite the methods and/or therapies used. The 
symptoms of withdrawal and those experienced in mental health disorders are highly comparable 
(Buckley, 2019). Aids to assist in cessation and those used for depression, for example, are often 
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one and the same. As the use of CM slowly increases, it increases the demand for accurate 
information about CM being shared among practitioners of all medical fields and to the general 
public.  
 
1.2 Aim and objectives 
 
1.2.1 Aim  
The aim of this study was to determine the use of various CMs in the cessation of cigarette smoking 
in Johannesburg, South Africa, by surveying smokers and former smokers.  
 
1.2.2 Objectives  
The objectives of this study were to assess links between background information, smoking 
patterns and the use of CM in cigarette smoking cessation. This study will provide an indication of 
the underlying reasons why people smoke and why quitting is such a challenge. It will also give 
insight into the CMs which are currently being used to aid in quitting and how effective they were 
in aiding in a successful quit attempt leading to abstinence. This knowledge assists in deepening 
our understanding of smoking cessation and the potential means in which we, as health care 
providers, can assist in cessation. This study highlights the need for action across all health care 
practices and education on smoking and the cessation thereof to all. 
 
1.3 Importance of the study 
This is the first study to explore CM use in smoking cessation in Johannesburg. There is currently 
little to no information on this in South Africa. The results present valuable insights into the CMs 
commonly used in cessation, the causes of relapses during quit attempts, the knowledge of CM and 
the willingness of smokers to use CM to quit. The impacts smoking has on one’s mental, physical 
and emotional health, finances, relationships and social life, among other impacts, urge the 
importance of promoting cessation in the most effective and healthiest ways, largely, for the benefit 
of the smokers, but also for the benefit of loved ones, the environment, and the community. 
 
1.4 Expected outcomes 
This survey will provide insight into CMs that have been used in smoking cessation. This study 
will allow for a further understanding of possible causes of smoking relapses, while also 
quantifying participants’ knowledge of CM and their willingness to use it for future smoking 







Smoking is defined as the inhalation and exhalation of smoke from burning tobacco in forms such 
as cigarettes, cigars and pipes (Oxford Learner's Dictionaries, 2019). Various substances or plant 
matter can be smoked and may include hashish, marijuana and tobacco (Sweanor et al., 2020). 
Tobacco is the most commonly smoked substance, usually smoked in the form of cigarettes. 
 
Smokers must be categorised so that it can be accurately determined whether or not they are 
considered a smoker. This categorisation is based on the number of cigarettes smoked in one’s 
lifetime and the frequency of smoking. The Centres for Disease Control and Prevention (CDC) 
(2017) categorises smokers as follows: 
• Smoker: an adult, who in their lifetime has smoked 100 cigarettes or more and who currently 
smokes cigarettes; 
• Former smoker: an adult who has smoked 100 cigarettes in their lifetime but has quit; and 
• Never smoker: an adult who has smoked less than 100 cigarettes or never smoked in their 
lifetime.  
 
Smokers can also be classified into different types, based on their reason for smoking. The types 
of smokers include: 
• Social smoker: one who only smokes in certain social settings. There is no dependency or 
desire to smoke outside of these settings; 
• Stressed out smoker: one who only smokes when stressed or one who smokes an increased 
amount when stressed. Approximately 47% of smokers claim that smoking reduces their 
stress levels; 
• Committed smoker: one who enjoys smoking and is addicted to nicotine or the act of 
smoking. This kind of smoker has no concern for the health risks posed by smoking and is 
not inclined to attempt to quit;  
• Skinny smoker: one who engages in smoking to stay slim. This is one of the most common 
reasons for smoking as 50% of females and 25% of males express this as their reason to 
smoke; 
• Sneaky smoker: a smoker who has no desire to quit and is ashamed to smoke around those 
that they care about, so they engage in secret smoking; 
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• Rebel smoker: one who smokes as an act of rebellion and creates the habit of and addiction 
to smoking. This commonly occurs in the teenage years; and the 
• Serial quitter: one who endeavours to cease smoking and repetitively attempts to quit, only 
to start again, thereby never achieving cessation. Sixteen% of smokers are serial quitters 
(Jozsef Wolfe, 2013).  
 
2.1.1 History of smoking 
Tobacco has been used for more than 2000 years, either chewed or smoked, in cultural and religious 
ceremonies. The discovery of smoking is credited by anthropologists to an injured, tired man 
resting beside a burning shrub of tobacco. They suggest that by breathing in the fumes from the 
burning shrub, the man felt somewhat healed (Raney, 2020). The use of tobacco can be dated back 
to 5000 BC and was first grown in the Andes. The plant made its way to Brazil through indigenous 
tribe migration and arrived in America in 1492, when Christopher Columbus did. By 1530, the 
plant arrived in and started to become more prevalent among Europe, as it was cultivated by the 
Portuguese royal family (Cruz, 2020). In the 1600s, tobacco was used as a monetary standard, 
which lead the tobacco industry to be well established by the 1700s (Brandt, 2019). Tobacco was 
used to “cure” various things from toothache to dressing wounds and decreasing pain (Swedish, 
2019). 
 
The first health considerations regarding smoking were made in 1602, when an English author 
believed that the illness that was produced by smoking was similar to the illness that was produced 
by the soot from chimney sweeping; cancer links became prevalent by 1795 (Brandt, 2019). 
Massachusetts passed a state law in 1632, making public smoking illegal; this was the first recorded 
legislation concerning smoking (Swedish, 2019). Mass production of tobacco cigarettes began in 
the 1800s. Medical reports on the association of smoking and lung cancer were published in the 
1920s (Brandt, 2019). Lip cancers were identified as more prevalent in pipe smokers around 1795. 
It was confirmed in the 1950s to 1960s that smoking caused various diseases. Cigarette smoking 
increased due to advertising, and their use to “boost morale” during WWII (Brandt, 2019).  
 
The manufacture of tobacco cigarettes evolved to increase the shelf life of tobacco. This was done 
by using additives which also made the cigarettes burn in a specific way, ensuring that the moisture 
content was controlled, masking the irritation caused by nicotine and adding aromas and flavours 
to the cigarettes (Sweanor et al., 2020). Proctor states: “The cigarette is the deadliest artefact in the 




Tobacco is the common name for Nicotiana tabacum L. (N. tabacum). There are more than seventy 
different tobacco species of which almost all originate from South America. Across Europe, 
oriental tobacco, commonly known as “Turkish tobacco” and scientifically as Nicotiana tabacum, 
is grown and used in cigarette and pipe production. This tobacco is small-leafed, highly aromatic 
and sun-cured. Another strain known as Nicotiana rustica is a wild tobacco native to Mexico and 
various parts of South America. It is commonly used for pesticides and tobacco dust (DAFF, 2015).  
 
A mature tobacco plant is about 50 cm tall and 25 cm wide, large and thick-stemmed, with oval-
shaped leaves (Trueman, 2020). The stems and underside of the leaves are covered in hairs. Large 
clusters of five-petal flowers grow in red, pink, white or cream colours. The most essential part of 
this plant is the leaves, which form tubular shapes and reach heights of 3.5 cm to 5.5 cm. The root 
system is adventitious or fibrous (DAFF, 2015).  
 
Tobacco grows in tropical, subtropical or temperate habitats. It is a sensitive plant that requires an 
average temperature between 20C to 30C to grow and 100 to 120 frost-free days between 
transplantation and harvesting. Well-distributed rainfall is an essential part of this plant’s active 
vegetative growth stage, with the humidity of 70% to 80%. Loamy, well-draining soil with a pH of 
5 to 6.5 is best for the tobacco plant. A rooting depth of 76.2 cm is preferable (DAFF, 2015).  
 
For tobacco to be consumed, it must first be cured. The curing process is done to change the colour 
of tobacco to decrease the amount of chlorophyll present. Curing involves various physical and 
chemical changes to the plant. The process includes browning, yellowing, wilting or colouring and 
drying. This takes six to eight weeks to complete. The temperature during the curing phase should 
be between 17C to 32C and a humidity of 70% to 75%.  The majority of the biochemical and 
chemical changes occur during the yellowing and drying phases (Reynolds, 2020).  
 
During the curing process, chlorophyll decomposes causing the yellow pigment of the plant, 
leading to chlorophyllides and phytol being formed. These constituents cause hydrolysis of starch 
to free sugars, of which some become carbon dioxide. Proteins are hydrolysed into free amino acids 
that react with the free sugars forming Amadori compounds (a variety of acids). Volatile 
constituents are formed through the thermal degradation of leaf surface sugar esters and diterpenes 
due to changes in polyphenols, leading to nitrate converting into nitrite. Tobacco specific 
nitrosamines are formed through the reaction with tobacco alkaloids and nitrite, which give cured 
tobacco products their characteristic aroma and flavour (Reynolds, 2020).  
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The various curing methods include: 
• Air - the tobacco is hung for four to eight weeks in a well-ventilated barn. This method 
allows for low sugar levels, giving high nicotine content and a light, sweet flavour. This is 
commonly done for cigar manufacturing;  
• Fire – low, continuous smouldering fires made using hardwoods are used to fire-cure 
hanging tobacco in barns for three days to ten weeks. This also produces high nicotine and 
low sugar content. This method is used for pipes, snuff and chewing tobacco manufacture;  
• Flue - the tobacco leaves are hung from tier poles, on tobacco branches. It is exposed to 
heat and not smoke. The temperature is gradually increased over the curing process. This 
takes approximately one week. This method produces tobacco with a medium to high 
nicotine content and high sugar content, which is done for cigarette production; and  
• Sun – this is a simple method whereby the tobacco is dried, uncovered in the sun. The 
tobacco is low in sugar and nicotine and is typically used for snuff and cigarettes (DAFF, 
2015). 
 
The leaf is the part of the plant that contains nicotine. Nicotine is, however, made in the plant roots 
and transported by the xylem to the leaves (Trueman, 2020). The tobacco plant has the following 
chemical components: ammonia, nicotine, glutamine, asparagine, - amino nitrogen, sulphur, 
phosphorus, chlorine, nitrate, protein nitrogen, formic acid, citric acid, malic acid, oxalic acid, 
dextrose, calcium pectate, calcium, potassium and magnesium. The amount of each constituent 
varies based on the method of curing that the tobacco undergoes, as well as the tobacco species 
(Leffingwell, 1999).  
 
2.1.3 Cigarettes 
Cigarettes are cylindrical shaped tobacco products. The tobacco is finely chopped and cured and 
rolled in thin paper along with a filter, chemicals and additives (NIH, 2020a). The filter is made 
using a plastic called cellulose acetate which takes up to ten years to decompose. This filters a very 
small fraction of the harmful chemicals inhaled from the burning cigarette and is toxic to many 
wildlife species. Filters provide a smooth inhalation during smoking, making it a more enjoyable 
experience than smoking without a filter (Lazarus, 2019).  
 
A single cigarette contains more than 4 000 chemicals. These include carbon monoxide, benzene, 
cyanide, tar, formaldehyde and more, many of which are carcinogenic (Team, 2019). Of these, 
nicotine occurs naturally in the tobacco plant, while some chemicals may have been absorbed from 
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the air, soil or fertiliser during plant growth, or be used in various cleaning products. The remainder 
of the chemicals found in cigarettes are added during processing of the tobacco and cigarette 
manufacturing for reasons mentioned previously and further discussed below (CRUK, 2018).  
 
The rolling paper contains chemicals that control the mode and speed with which the cigarette 
burns. Some of these chemicals including nicotine and unsaturated aldehydes, are there to ensure 
pain-free or cough free smoking. Coughing is a protective mechanism to expel foreign material and 
irritants from the body. It is a reflex whereby an inhale which causes increased intrapulmonary 
pressure rapidly, is followed by a forceful exhale, which brushes foreign or irritant material 
upwards to the pharynx for expulsion out the mouth (Grace et al., 2011). The chemicals inhaled 
during smoking inhibit the cough reflex, thus allowing one to smoke and cough less or not at all. 
This adds to the addictive properties of cigarette smoking (FDA, 2017). 
 
The amount of tobacco per cigarette is not typically measured, however, the amount of nicotine is, 
and it varies from 6 mg to 28 mg per cigarette. On average there is 10 mg to 12 mg of nicotine in 
one cigarette. After consuming one whole cigarette, about 1.1 mg to 1.8 mg of nicotine is inhaled 
(Jewell, 2019).  
 
2.1.4 Prevalence of smoking 
Globally, 1.1 billion people are tobacco smokers, with the highest rate of smoking occurring in 
men (WHO, 2018a; WHO, 2018b). Worldwide, roughly 18 billion cigarettes are smoked daily, 
totalling 6.5 trillion cigarettes smoked each year (Martin, 2018).  
 
In South Africa, 16.5% of the population smoke cigarettes, causing 44 000 smoking-related deaths 
each year and 121 deaths daily (Jacob, 2018). Approximately 7 million South African adults are 
cigarette smokers. Of the total population of males interviewed, 29% were smokers and of the total 
population of females interviewed, 7% were smokers, indicating that males are four times more 
likely to smoke than females. Smokers aged 15 years and older together, smoke a total of 27 billion 
cigarettes annually (Rataemane, 2019; Reddy, 2018). Smoking in females occurs most commonly 
in white and coloured populations, between the ages of 55 and 64 years, and occurring at its highest 
rate in urban areas. Among males, coloured, indian and asian racial groups, aged between 45 and 
54 years old, have the highest prevalence of smoking. In Gauteng, the prevalence of smoking is 
much smaller compared to other provinces in South Africa (Lehohla, 2018).  
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2.1.4.1 Smoking and the economy 
Smoking has a large effect on the economy. These effects are seen in many areas including health 
care, employment and the general economy (Brown, 2015). The average annual amount lost 
globally is US$ 1,4 trillion due to finances spent on health care and productivity lost due to 
smoking. This is equivalent to 1.8% of the world’s gross domestic product (GDP) (WHO, 2020c). 
An average of 15% of health care expenditure can be attributed to smoking. In Britain, this equates 
to about 5% of the NHS annual budget, thus between 2.7 billion to 5.2 billion Pounds (Brown, 
2015). In South Africa, the economic cost of smoking in 2016 was R33 billion (Kofi Boachie et 
al., 2016). The reduction of cigarette smoking and an increase in smoking cessation would lead to 
a decrease in the rate of non-communicable diseases and have a positive impact on the economy 
and health care expenses (WBG, 2017).  
 
Productivity is largely affected in the workplace due to time spent smoking at work and time taken 
off from work due to smoking-related illnesses. In the US, this leads to US$ 151 billion lost 
annually (Brown, 2015). Illness and loss of productivity due to smoking lead to a value of R290 
million being lost in 2016 (Kofi Boachie et al., 2016). Mental health improvements are also seen 
with smoking cessation which improves general morale and productivity in the workplace 
(Tobacco Atlas, 2020).  
 
Smoke-free workplaces are highly beneficial to companies and the economy. Enforcing a smoke-
free workplace encourages cessation and ultimately decreases the prevalence of cigarette smoking. 
This saves the economy money in terms of private health care expenses and leads to a more 
productive workforce. The economic effect of the cost of smoking far outweighs the benefit 
(Brown, 2015).  
 
The cost to the economy is large, however, there is economic benefit in the form of taxes received 
from cigarette sales and job creation from cigarette manufacturing. This is most beneficial in high-
income countries. The most effective means of reducing tobacco consumption is to increase taxes 
on tobacco products. A decrease of 4 to 8% in the prevalence of cigarette smoking can be seen 
from a 10% tax-induced price increase The taxes received from cigarette consumption are only 
really beneficial to the economy when tax rates are between 42.9% and 91.1% (Brown, 2015). 
 
Increased taxes on tobacco products and legal bans on tobacco products are effective in decreasing 
the negative effect that cigarette smoking poses on the economy. If the prevalence of cigarette 
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smoking is decreased, the impact on the economy in terms of job loss, tax income loss and 
impoverished smokers is recognised, but outweighed by the benefits (WHO, 2020c).  
 
The WHO suggests that during tax increase considerations, that all tobacco products be included 
and not merely cigarette tax rates. This would help eliminate other products for tobacco use being 
founded and enabling tobacco use outside of cigarettes. Increased taxes may negatively affect poor 
smokers and add financial burden to such families, however, it is in the interest of their health that 
the increases occur, aiming to lead to smoking cessation overall. Once they have stopped smoking, 
they will be saving money which could then be used towards food and education (WHO, 2020c).  
 
Additional tax income can be used by the government to facilitate improved health care and 
education, and provide for the basic needs of communities. These funds can also assist in smoking 
cessation programmes, thereby improving public and economic health (WHO, 2020c). 
 
2.1.4.2 Smoking and society 
Smoking affects the health of smokers and of those around them that are exposed to the second-
hand smoke. Second-hand smoke is involuntarily inhaled smoke from tobacco or other products 
being smoked by others (Cambridge, 2020a). Second-hand smoke is also harmful to a non-smoker 
(Swedish, 2019). 
 
2.1.4.3 Smoking and the environment 
Tobacco production is harmful environmentally. The production alone causes mass deforestation 
in order to burn firewood used to cure the tobacco used in cigarette manufacturing. The pesticides 
used in tobacco farming are harmful to the farmers and farmworkers, the water and the land on and 
surrounding the tobacco farms. The environment is not only continually harmed by the pollution 
caused by smoking cigarettes, but also from fires caused due to cigarette butts and lighters being 
used and disposed of irresponsibly (Perucic, 2016).  
 
2.1.5 Physiological effects of smoking 
Cigarette smoke affects many organs and body systems when inhaled. Smokers are affected 
differently based on the type of cigarette smoked, the size of the cigarette, the volume of smoke 
inhaled, the depth of inhalation, the length of time the smoke is held in the lungs, and the frequency 
and intervals of smoke inhalation (Benowitz et al., 2013; CDC, 2010). 
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The respiratory and circulatory systems serve as the basic transport mechanisms for cigarette 
smoke in the body. On inhalation, the smoke passes down the trachea and larynx causing irritation 
of these organs. It then passes through the bronchi and reaches the lungs (bronchioles and alveoli), 
causing breathlessness and decreased lung function due to the narrowing and inflammation that 
occurs in response to the irritants and chemicals present in cigarette smoke. Mucous production is 
inhibited by Bik, a proapoptotic protein, which causes mucous-secreting cell death. This protein is 
suppressed by cigarette smoke inhalation allowing excess mucous to be produced (Mebratu, 2011; 
Mebratu et al., 2011).  
 
The impairment of the lung tissue caused by smoking leads to permanent damage of the tissue and 
increases the risk of respiratory infection, cancer, COPD and illness due to the decreased function 
of the mucociliary system (Victoria, 2019). This can be attributed to the structural abnormalities of 
the cilia, hypertrophy of mucous cells, epithelial remodelling and goblet cell metaplasia caused by 
cigarette smoke inhalation (Ramos et al., 2013). 
 
Cigarette smoking causes damage to the alveoli through cell death in the form of necrosis or 
apoptosis, increased ROS (Reactive Oxygen Species) levels and glutathione depletion (Nagai, 
2003). Thinner, less effective alveolar sacs remain. This decreases the amount of oxygen absorbed 
and carbon dioxide expelled by the lungs  (Martin, 2020a). The repair functions of mesenchymal 
cells, fibroblasts and epithelial cells are impaired by smoking and can lead to DNA damage and 
make apoptosis less effective. The body attempts to repair damaged DNA, however, mutations may 
occur during cell division, which may lead to pathological lung changes and cancers in the lungs 
and throughout the body (Rennard et al., 2006). 
 
At the alveoli, the chemical content of the smoke is transported into the bloodstream through the 
capillaries. The nicotine and carbon monoxide cause epithelial dysfunction due to increased 
epithelial permeability, decreased surfactant production and cell death, which leads to impaired 
glucose regulation and blood lipoprotein abnormalities. These factors further complicate arterial 
function by causing the development of atherosclerotic plaques, causing a hardening, narrowing 
and decreased elasticity of the arterial wall as well as impaired blood flow and potential arterial 
rupture. Endogenous epinephrine is released directly and indirectly by nicotine during smoking, 
increasing platelet aggregation and activation. The presence of atherosclerotic plaques combined 
with increased platelet activation results in thrombosis (Greenhalgh et al., 2020). 
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During this transportation of the smoke into the bloodstream, there is activation of neutrophils, 
platelets, monocytes, T-cells and endogenous free radicals. The free radicals are directly transferred 
to the lungs from the smoke and lead to increased oxidative stress, which occurs when there is an 
imbalance between antioxidants and free radicals in the body. Free radicals are oxygen-containing 
even-numbered electron molecules. Free radicals cause reactions called oxidation, which are large 
chain chemical reactions. (Legg, 2017). Oxidative stress leads to the activation of inflammatory 
genes and increased cytokines, causing cell damage which results in disease. Vasomotor 
dysfunction, platelet and leukocyte activation, increased prothrombotic and decreased fibrinolytic 
factors, increased lipid peroxidation, smooth muscle proliferation, and increased adhesion and 
inflammatory molecules all occur as a result. Therefore, leading to the initiation and progression 
of atherothrombotic diseases (Ambrose, 2004).  
 
Endothelial dysfunction occurs due to the reduction in vascular nitric oxide bioavailability caused 
by tobacco smoke, causing platelets to adhere to one another and macrophages to produce an 
inflammatory and procoagulant environment (Messner and Bernhard, 2014).  
 
Nicotine causes myocardial ischaemia; due to an increased myocardial demand for oxygen and 
nutrients; and atherosclerosis, however, the most detrimental effect of nicotine on the 
cardiovascular system, is hypoxaemia. Carbon monoxide from cigarette smoke binds to 
haemoglobin, decreasing its oxygen-carrying capacity, thereby less oxygen is circulated to the cells 
of the body resulting in hypoxemia. Hypoxemia increases the blood viscosity and the occurrence 
of ventricular arrhythmia (Bullen, 2008).  
 
Blood passes through the lungs allowing the exchange of gas via the capillaries that share the 
alveolar walls. Oxygen binds to haemoglobin which is transported throughout the body by the 
bloodstream. Nicotine is transported from the alveoli to the circulatory system in the same manner. 
It then travels via the blood to the brain within 10-20 seconds of inhaling tobacco smoke. This is 
faster than it would take to reach the brain by intravenous administration. Smoking is the fastest 
method of delivering nicotine to the brain and is part of the reason people smoke instead of using 
other methods of nicotine administration (Benowitz et al., 2013; CDC, 2010). Nicotine causes the 
release of dopamine, serotonin, GABA, glutamate and acetylcholine in the brain. These play 
specific roles in terms of mood, memory, reward and concentration (Smith, 2019).  
 
Smoking harms the health of the liver and kidneys. It increases the incidence of renal artery 
stenosis, increase albumin excretion in urine, decreases glomerular filtration rate and increased 
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glomerular inflammation in the kidneys (Mishra et al., 2015). Smoking increases the production of 
proinflammatory cytokines and promotes oxidative stress of hepatocytes which in turn lead to 
fibrosis (El-Zayadi, 2006). Nicotine is metabolised in the liver by the enzymes CYP2A6 
(Cytochrome P450 Family 2 Subfamily A Member 6), UGT (UDP-glucuronosyltransferase) and 
FMO3 (flavin-containing monooxygenase3) and is converted to cotinine. Nicotine that is converted 
to nicotine glucuronide in the liver by UGT enzymes is excreted in the urine. Only about 3 to 5% 
of the nicotine ingested and metabolised is excreted; of which, 10 to 15% appears as unchanged 
cotinine in the urine (Benowitz et al., 2013; CDC, 2010). Measuring cotinine in the blood is an 
accurate way of measuring nicotine exposure, as it remains in the body longer than nicotine (CDC, 
2017b). 
 
Cigarette smoking is suppressive to the immune system as it affects adaptive and innate immunity 
by exacerbating pathological immune responses or attenuating defensive immune responses (Qui 
et al., 2016). Smoking causes the release of pro-inflammatory cytokines like interleukin (IL) -17A, 
IL-1, IL-6, IL-8 and tumour necrosis factor  (TNF-), as well as IgE. These cytokines cause local 
irritation in the lungs in the form of inflammation and increase white blood cell activation (Strzelak 
et al., 2018). The number of T cells, macrophages, dendritic cells and neutrophils are increased in 
the airway and contribute to chronic airway inflammation, which leads to chronic tissue injury and 
remodelling, while the extracellular matrix degenerates and fragments of it are released in the 
peripheral airway wall, resulting in scar tissue formation and blockage of airflow from airway 
obstruction (Lee et al., 2012; Sonbol, 2018). The effects of the inflammatory mediators are 
proportionally based on the frequency of smoking, the amount of nicotine and tar per cigarette and 
how long smoking has occurred for (Lee et al., 2012).  
 
Chemical exposure during cigarette smoking poses negative health effects. The main chemicals 
absorbed, along with their negative effects on the body are discussed below: 
• Nicotine: increases blood glucose levels, blood pressure and heart rate;  
• Polyaromatics: are known human carcinogens and cause DNA mutations and affect 
reproductive capabilities; 
• N-Nitrosamines: cause reproductive damage and are known carcinogens; 
• Acrolein: is a skin and nasal passage irritant that causes DNA mutations, is carcinogenic 
and contributes to heart disease;   
• Benzene: decreases red blood cell count, is carcinogenic, harmful to reproductive organs 
and damages bone marrow;  
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• 1,3-Butadiene: is teratogenic and carcinogenic and an upper respiratory tract, eye and skin 
irritant;  
• Aromatic amines: are associated with bladder cancer and are a known carcinogen; and  
• Acetaldehyde: is a respiratory tract, skin and eye irritant, and an animal and human 
carcinogen (Fowles, 2014).  
 
2.1.6 Impact of smoking on health 
Reasons for smoking may include pleasure, stress relief and social habituation. Addiction to 
nicotine and the marketing of tobacco products both play a role in the continuation of smoking 
(Rosen, 2015). However, smoking poses significant negative effects to the health of smokers, 
which significantly outweigh any potential positive experiences of smoking; such as pleasure, 
stress relief, calming, relaxation and enjoyment of the taste of the cigarette. Globally, tobacco use 
causes more than 8 million smoking-related deaths every year and an additional 1.2 million annual 
deaths due to second-hand smoke exposure (WHO, 2019a). The diseases related to smoking that 
are linked with this morbidity include dementia, diabetes mellitus type II, Crohn’s disease, obesity 
(in heavy smoking, ±40 cigarettes p/d (per day)), coronary heart disease, lung cancer and stroke 
(Gadye, 2018).  
 
Smoking is estimated to be the third-highest cause of death globally by 2030 and is currently the 
primary risk factor for Chronic Obstructive Pulmonary Disease (COPD). Smoking increases the 
risk of cancers, pneumonia, tuberculosis, ischaemic heart disease and stroke. The death rate in 
smokers is almost double that of ex-smokers and non-smokers (Zyl-Smit, 2013). It affects bone, 
tooth and gum health. It increases the risk of cataracts and age-related macular degeneration. 
Smoking increases the risk of diabetes mellitus type II by 30 to 40% and makes it much less 
controllable (CDC, 2018a). 
 
Smoking has been found to contribute to more deaths than illegal drugs, Human Immunodeficiency 
Virus (HIV), alcohol and car accidents combined. Its effects on the respiratory system are 
significant, contributing to 90% of lung cancer deaths and 80% of COPD cases and deaths (CDC, 
2018a). Almost 50% of smokers die from smoking related ailments. Smoking decreases fertility in 
both females and males, with an increase in erectile dysfunction in males. Women who smoke have 
an exponentially increased risk of cervical cancer and stroke (Team, 2019). 
 
Second-hand smoke causes health implications and risks too. There are many cases of morbidity 
due to illnesses caused by exposure to second-hand smoke. In children, it causes more severe and 
14 
frequent asthma attacks, ear infections, respiratory infections and respiratory symptoms, like 
coughing and sneezing. The risk of sudden infant death syndrome is also increased. In adults, the 
risk of stroke, heart disease and lung cancer is increased (CDC, 2018b). 
 
2.1.6.1 Associated diseases 
This section discusses diseases and illnesses and their association with cigarette smoking. 
 
Diseases associated with smoking include: 
• Lung cancer – lung cancer has the highest death rate of all cancers. Cigarette smoking is 
the number one risk factor for lung cancer. Of all lung cancer deaths, 87% are due to 
cigarette smoking (ALA, 2020a). Cigarette smoking increases the risk of lung cancer by 15 
to 30% compared the risk seen in non-smokers or never smokers. Longer-term smoking 
also increases the risk of lung cancer (CDC, 2019). 
• COPD – cigarette smoking is the cause of 80% of COPD cases and deaths (ALA,2020a). 
Long term exposure to second-hand smoke also contributes to COPD. When children and 
teenagers are exposed to second-hand smoke, it slows down the development and growth 
of their lungs, which poses an increased risk of COPD later in life (CDC, 2020a). 
• Heart disease – smoking causes arterial narrowing and the formation of thrombi. This 
causes decreased blood flow and oxygen to the heart itself when the arteries to the heart 
become affected (ALA, 2020a). As previously mentioned, carbon monoxide from cigarette 
smoke causes hypoxia. Increased oxygen demand puts added strain on the heart because it 
requires increased cardiac output through the circulatory system to areas in need. Increased 
workload on the heart and circulatory system thus increases the risk of circulatory and heart 
disease (BHF, 2019).  
• Stroke – as previously mentioned, atherosclerosis caused by cigarette smoking increases 
the risk of stroke. Thrombotic emboli causing a lack of blood supply to the brain results in 
stroke. Strokes are a leading cause of disability in adults and the fifth cause of death in the 
United States (ALA,2020a). In South Africa, an estimate of 33 500 strokes occurred in 
2011, with 114 deaths per 100 000 persons per year from 2007 to 2011 (Maredza et al., 
2015). The more smoke one is exposed to, the higher the risk of stroke. This is also true of 
second-hand smoke exposure (Cole & Shah, 2011). 
• Asthma – a chronic lung disease is worsened by cigarette smoking and exposure to second-
hand smoke. Smoking may bring on asthma attacks which are sudden and severe (ALA, 
2020a). This is problematic because frequent and severe attacks may lead to future 
development of COPD and other more serious respiratory disorders (ALA, 2020b). 
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• Infertility and premature childbirth – smoking affects fertility by damaging the genetic 
material in the egg and sperm which leads to spontaneous abortions and birth defects. 
Smoking during pregnancy leads to low birth weight which increases the risk of diabetes 
mellitus type II, cardiovascular disease and obesity in adulthood. Infertility rates are 
increased due to the chemicals in cigarettes, like carbon monoxide, nicotine and cyanide, 
causing an increased egg loss rate (ASRM, 2014). Late pregnancy bleeding and premature 
membrane rupture may cause premature birth; as it is speculated that the vasoconstrictive 
effects of smoking cause placental hypoperfusion of the placental vasculature; leading to 
ischaemia, haemorrhage and necrosis and thus placental separation (Kaminsky et al., 2008; 
Kyrklund-Blomberg et al., 2005). Premature birth may cause the infant to have 
underdeveloped lungs and brain or defects like a cleft palate or lip (CDC, 2020b).  
• Diabetes – smoking increases the risk of diabetes mellitus type II by 30 to 40% compared 
to non-smokers or never smokers. Smoking disrupts glucose homeostasis and increases the 
risk of complications regarding the kidneys, liver, heart, circulation and blindness in 
diabetics. The leading cause of blindness, a common complication of diabetes, in people 
over 65 years of age is macular degeneration which may be caused and/or accelerated by 
cigarette smoking, done by numerous diabetic patients (ALA, 2020a). 
 
2.1.7 Tobacco addiction  
Tobacco is an addictive product, due to the presence of nicotine. Many people find it difficult to 
stop smoking once they have started, despite the negative health consequences. Multiple elements 
play a role in delivering a specific amount of nicotine to the body to contribute to addiction but not 
too much that it makes smoking unenjoyable (Benowitz et al., 2013; CDC, 2010). 
 
As previously mentioned, once inhaled, nicotine in the blood travels to the brain within 10-20 
seconds, providing highly controlled doses of nicotine to the brain. Nicotine’s structure resembles 
that of acetylcholine and attaches to the nicotinic acetylcholine receptors of the brain in the 
mesolimbic dopamine system, the brain’s reward centre. This is located at the nucleus accumbens, 
which is the centre of all addictive behaviours. Nicotine causes a release of dopamine in the nucleus 
accumbens, leading to a pleasure response that smokers desire to repeat. Nicotine has the additional 
action of inhibiting Mono-amine oxidase (MAO). Physiologically, MAO deactivates dopamine by 
deamination. When this action is inhibited by nicotine, dopamine’s structure remains unaltered; the 
increased volume of unaltered dopamine leads to improved mood and decreased levels of 
depression (Lande, 2018). Nicotine withdrawal results in a dopamine deficit, meaning that tonic 
dopamine signals and basal dopamine concentration during nicotine withdrawal are much lower 
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than phasic dopamine signals. The phasic signals cause one to seek the stimulus that causes the 
dopamine release. This response is heightened in addiction, making it harder to stay abstinent once 
quitting (Zhang, 2012). 
 
Nicotine also causes the release of endorphins and corticosteroids, which are responsible for fatigue 
reduction and increased information processing. They also induce euphoria and reduce anxiety 
(Lande, 2018). When nicotine attaches to the nicotinic acetylcholine receptors in the brain, other 
neurotransmitters including norepinephrine, serotonin, endorphins, acetylcholine, GABA and 
glutamate are also released (Widysanto et al., 2020). Nicotine prolongs and enhances the pleasure 
experienced with various activities. The neurotransmitters released by nicotine stimulation lead to 
arousal, pleasure, decreased anxiety, appetite suppression and mood enhancement (IPRC, n.d.).  
 
2.1.8 Smoking controls 
 
2.1.8.1 International controls 
The pre-eminent global tobacco control instrument is called the WHO Framework Convention on 
Tobacco Control (WHO FCTC). This provides legalities surrounding the supply and demand for 
tobacco products with policies containing directions on how to control tobacco at all levels (WHO, 
2020a). Various aspects included are smoke-free environments, warning labels, advertising bans, 
monitoring, cessation programmes, mass media campaigns and taxation (WHO, 2020b).  
 
For ease of implementing these instruments, an acronym was formed introducing a package of 
measures called MPOWER. It stands for the following: 
• M – Monitor tobacco use and prevention policies 
• P – Protect people from tobacco smoke 
• O – Offer help to quit tobacco use 
• W – Warn about the dangers of tobacco use 
• E – Enforce bans on tobacco advertising, promotion and sponsorship 
• R – Raise taxes on tobacco (WHO, 2020a) 
 
Using these measures, countries around the world are able to report and monitor all elements of 
MPOWER and note what is working and what is not, in order to decrease the prevalence of 
smoking globally. These comprehensive tobacco control measures enable a wider spread of 
information and help to assist cigarette smoking cessation. The more countries that participate, the 
better the result (WHO, 2020a).  
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2.1.8.2 Court cases 
Tobacco control is aimed at preventing disease and saving lives. This is of high importance as 
tobacco kills one in two of its regular users. Controlling tobacco use is made exceptionally hard by 
tobacco industry tactics which target new and younger users continuously. Many court cases are 
documented regarding cases against the tobacco industry, dating back to 1954. Tobacco companies 
often won their cases by denying that tobacco causes disease. Once proven otherwise, they argued 
that the hazards of smoking are of common knowledge (Blanke, 2002). 
 
In the 1990s, new legal theories and forms of aggregated litigation meant that tobacco companies 
could no longer blame victims as defence mechanisms. Following this new litigation, multiple large 
cases have been successful and show how effective tobacco controls can be. Although success has 
been seen, it emphasises the need for litigation as many cases against tobacco companies still fail 
(Blanke, 2002). 
 
Clear litigation patterns are still in process worldwide. This will lead to advancements in tobacco 
control over time. Rights that protect workers and consumers from the dangers of second-hand 
smoke exposure are advancing. Health care costs surrounding smoking are also being considered 
in new litigation; while restrictions on public smoking have a large input in tobacco control. In 
order to appropriately control tobacco, cases in the illicit trade of tobacco products are of high 
possibility for investigation. Medical evidence is a key part of legal action being allowed to take 
place, without which, the power for public debate is decreased. The majority of cases involve 
illness, the costs thereof and the loss of life (Blanke, 2002). 
 
Tobacco litigation is very costly and needs to be carefully approached. It is also difficult to 
standardise litigation as each country has its traditions and unique circumstances which impact 
litigation differently. For global success in litigation, countries need to collaborate (Blanke, 2002). 
 
In 1964, it was reported that cigarette smoking causes lung cancer. This was when the “lack of 
knowledge regarding health risks” changed to “it is common knowledge that smoking has health 
risks” according to tobacco companies (Blanke, 2002). Ultimately, the aims of litigation and court 
cases are to advance comprehensive tobacco control frameworks globally, to decrease the smoking 
prevalence and increase the overall health of the community (Blanke, 2002).  
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2.1.8.3 Money and power 
The tobacco industry was estimated to be worth US$ 923 billion in 2019. The industry remains 
powerful and financially strong because multiple companies and manufacturers supply tobacco 
companies with the materials necessary for the manufacture of cigarettes. Raw materials such as 
tobacco, filters, rolling paper, filter paper, glue and paper laminated with aluminium are mass-
produced by other industries and supplied to tobacco companies to sustain their activities (Wood, 
2019).  
 
With tax increases leading to decreased consumption of cigarettes in developed countries, 
developing countries have seen an increase in their consumption as the target of marketing has 
shifted as a result. Tobacco companies go to large extents to get cigarettes into countries in large 
scales. Smuggling of cigarettes is just one example of such extents. The use of different advertising 
strategies is evident. Strategies include appealing to the youth, impressions of a glamorous lifestyle, 
appeals based on gender and advertising different tar levels between developed and developing 
countries (Bates and Rowell, 2019).  
 
Tobacco control has been a challenging task globally for various reasons. The tobacco industry is 
a powerful and high money-making one; where negotiations are made with communities that would 
largely benefit from the financial influx, without always being aware of the negative aspects that 
come with this trade. High demand leads to brands fighting for fame in the cigarette world; leading 
an ever-growing industry with increased impacts on the cost to the economy and communities 
(Bates and Rowell, 2019; WHO, 2017).  
 
2.1.8.4 Legislation in South Africa  
South Africa has been part of the WHO FCTC since 2005 (Tobacco Control Laws, 2019). Smoking 
is allowed publicly, however, not in “partially enclosed” areas like verandas, patios, balconies and 
walkways. Fines may be given to individual persons and/or businesses that do not comply with 
these laws. Adults may not smoke in the car with a child under 12 years of age present. Any 
premises used for schooling, tutoring or childcare may not be smoked in. Anyone under the age of 
18 is not allowed in designated smoking areas, nor are they allowed to smoke or purchase cigarettes 
(CANSA, 2009).  
 
Restrictions on outdoor smoking areas have been implemented. All areas used for public transport, 
sports stadia, healthcare facilities and entrances to buildings are prohibited smoking areas and are 
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under strict regulation (CANSA, 2009). The legislation prescribes that smokers must be a minimum 
of 10 metres away from the public entrance of a building (Rocheleau, 2018; Writer, 2018).  
 
Prohibition of terms like “mild” or “low” tar may not be used in packaging as this falsely implies 
a “healthier” cigarette. Harmful additives and chemicals used in cigarette manufacturing need to 
be disclosed and are being regulated. Anything added to cigarettes must first be approved by the 
Cabinet of the Republic of South Africa (the Bill – in SA) before doing so (CANSA, 2009). 
Advertising and the promotion of cigarettes are prohibited, as is public sponsorship by tobacco and 
cigarette companies. Health warnings should be found on 15% of the front and 25% of the back of 
the cigarette box (Tobacco Control Laws, 2019).  
 
Several legal changes have occurred in South Africa regarding smoking with effect since 2018. 
These changes include: 
• Indoor smoking in public places and the removal of designated smoking areas in restaurants 
is now under a zero-tolerance policy; 
• Retailers may no longer publicly display cigarettes; 
• Certain public spaces are now banned from outdoor smoking; 
• Cigarette signage has also been regulated to only show the brand name of the cigarettes and 
warnings; 
• It is now banned to smoke in a vehicle with persons under the age of 12 years or if there is 
more than one person in the car; 
• Any toy or confectionary items that resemble tobacco products may not be sold; and 
• Fines and jail time penalties have been put into place for those that do not comply with 
these legalities and standards (Businesstech, 2018). 
 
2.1.9 Smoking cessation  
Several surveys conducted found that more than 70% of smokers would like to stop smoking but 
less than 3% are successful in stopping on their own. Many smokers who wish to stop smoking 
engage in what is known as a “quit attempt”. A “quit attempt” may be defined as having stopped 
smoking for one day or more, with the intention of quitting (CDC, 2017c). Those that are not 
successful in smoking cessation initially may attempt to stop smoking several more times 
(Lancaster et al., 2019).  
 
Once smoking cessation in achieved, there is a risk of relapse. Relapse is said to be ruled by two 
factors, namely cravings and compulsion. A craving is a strong feeling of wanting something 
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(Cambridge, 2020b). Cravings may be triggered by the environment, habits and associations. 
Cravings during smoking cessation can have a physical and physiological effect. The physical 
response is due to the nicotine withdrawal which leads to feelings of tension or tightness in the 
stomach and/or throat and may also include feelings of anxiety. The physiological response is 
usually due to certain triggers, like habits, for example, if one smoked every time they drove, 
getting into the car to drive may be a trigger that causes one to crave a cigarette. Stress and 
socialising may be other physiological causes of a cigarette craving (Martin, 2019c).  
 
A compulsion is a very strong feeling of wanting to do something repeatedly that is difficult to 
control (Cambridge, 2020c). A compulsion is a forceful, unconscious drive that fuels relapse in 
cigarette smoking. This is due to nicotine addiction, which is why compulsions are so hard to 
control. When cravings and compulsions feel stronger than your willpower or desire to quit, they 
often win and thus relapse occurs (Martin, 2019c). 
 
In order to successfully quit smoking, one should create tactics to help avoid craving triggers and 
smoking compulsions. Tactics include knowing cigarette craving triggers, mindfulness and deep 
breathing, having a glass of water instead of reaching for a cigarette, remembering reasons for 
wanting to quit, ensure a good support system and being strict with hobbies and things put into 
place to assist with long term successful cessation (Martin, 2019c). Cravings can be brought on 
naturally by emotions; ensuring appropriate coping mechanisms are in place during the quit 
attempt, will be largely beneficial in cessation success (Team, 2019).  
 
Planned quit attempts are the most successful due to self-education. Here, pros, cons, rewards and 
strategies against cravings, are all considered. Planning a quit attempt means setting a date, time, 
place and manner to follow. This plan should consider any and all obstacles or challenges that one 
may face. A list of pros and cons surrounding quitting should be listed. A sound support system is 
vital when planning a quit attempt. This plan should include how triggers and cravings will be 
tackled and what reward system will be in place when milestones in cessation success and 
abstinence are reached. Smokers who plan a quit attempt have higher cessation rates than those 
who do not form a plan (Team, 2019).  
 
Cigarette consumption is decreased by tax increases, smoke-free workspaces and smoke-free 
public spaces. Social media and advertising of the negative effects of cigarette smoking also play 
a role in decreasing the number of cigarettes smoked. These campaigns often stress the dangers of 
smoking on one’s health and the environment. Enforcing smoke-free social settings like 
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restaurants, for example, makes smoking socially unacceptable, as well as illegal (Alamar & 
Glantz, 2006). 
 
Smoking cessation has an impact on the smoker (now ex-smoker), those around them, the 
environment and the economy. The health benefits are most important for the ex-smoker, as well 
as the decreased financial strain. This cessation has a benefit for second-hand smokers in terms of 
their health too. There is decreased pollution due to decreased smoke affecting the ozone layer and 
the waste and pollution created by the butts and packaging for example. The economy is able to 
improve due to decreased absenteeism in the workplace and medical services are not put under 
strain due to smoking and the complications and illnesses it causes and effects (Bonnie et al., 2015). 
 
Increased education on smoking and the health, financial and environmental economic implications 
thereof would decrease the rate at which people start smoking and increase the cessation rates too. 
By increasing the social rejection of cigarette smoking, a reduction in consumption should be 
prevalent (Alamar & Glantz, 2006).  
 
2.1.9.1 Health benefits of smoking cessation 
Tobacco smoking is one of the most preventable causes of premature death and ill-health 
worldwide (West, 2017). Smoking cessation is often accompanied by withdrawal symptoms, 
including head rush, chest tightness, chest pain, dry throat, dizziness, stomach pain, headaches, 
fatigue, cigarette cravings, restlessness, depression, frustration, anger, anxiety, increased appetite, 
weight gain, difficulty concentrating, insomnia, coughing, tremors, constipation and decreased 
heart rate (Buckley, 2019; Chetty, 2015). These symptoms are usually the worst in the first few 
days or weeks after quitting; this is the period that smokers are known to be most at risk of starting 
to smoke again (Rosen, 2015).  
 
There are multiple health benefits associated with cigarette smoking cessation. Several can be 
witnessed with immediate effect of cessation while other benefits occur over longer periods of 
abstinence (CDC, 2017a). Table 2.1 below discusses health benefits over specified periods, 
highlighting which symptoms improve and/ or decrease, as well as the different risks based on the 




Table 2.1: Health benefits of smoking cessation 
Period of time Associated health benefits over time 
Immediate benefits • Lowered blood pressure 
• Decreased risk of lung cancer, heart disease and stroke 
• Overall improved lung function (Zyl-Smit, 2013) 
Within 20 minutes  • Decreased heart rate to normal levels 
Within 12 hours • Blood carbon monoxide levels drop to normal 
2 weeks to 3 months • Improved lung function 
• Decreased risk of heart attack  
1 month to 9 months • Decreased coughing and shortness of breath (dyspnoea) 
12 months • Risk of heart attack decreases by 50% 
• Decreased frequency of COPD exacerbations 
• Cessation of cancer progression 
• Decreased level of stress and mood disorders 
• Increased happiness and general life satisfaction (West, 2017) 
2 years to 5 years • Stroke risk is reduced to that of a non-smoker  
10 years • Kidney and pancreatic cancer risk is decreased 
• Lung cancer death rate is half that of smokers  
15 years • Risk of coronary heart disease is decreased to that of a non-
smoker (CDC, 2017a) 
 
2.1.9.2 Smoking cessation aids 
There are a number of aids that are proposed to promote smoking cessation. It has been 
demonstrated that awareness of the benefits of smoking cessation help to motivate many people to 
stop (Terrie, 2019).  
 
Hobbies that keep the mind and hands occupied are the most beneficial in long-term smoking 
abstinence. Artistic hobbies have shown to be most beneficial, as they engage in the use of both 
the mind and the hands. Being creative is also therapeutic and may help with stress management; 
as a creative process is one that involves changes in thoughts, behaviours, feelings and perspectives, 
making it a good tool to assist in cigarette smoking cessation (Kaplan, 2017). Playing a musical 
instrument or reading additionally aid in craving cessation. Ultimately, keeping oneself busy is a 
large part of cessation and abstinence (Davos, 2020).  
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Various conventional medications are used to aid in cigarette smoking cessation and include: 
• Nicotine patch – a patch placed on clean and unbroken skin daily that releases between 5mg 
and 21mg of nicotine over 16 to 24 hours, depending on the type of patch used, which is 
absorbed through the skin. The type of patch used is chosen according to how many 
cigarettes are smoked daily by the smoker. The higher nicotine dose patch is usually used 
first and is changed to lower dose patches over time (Molyneux, 2004; Ogbru, 2020).  
• Nicorette – chewing gum that releases 2mg to 4mg of nicotine per piece when chewed. 
Different strengths are used based on the number of cigarettes smoked daily and are 
decreased over time. Nicotine gum should not be chewed like normal gum, instead when 
the peppery taste or tingling from the nicotine appears during chewing, one should move 
the gum between the cheek and teeth until the tingling subsides, then repeat chewing. This 
cycle is continued until no more tingling occurs, which indicates that the piece of gum 
should be discarded (Molyneux, 2004).  
• Anti-depressants – effective in reducing physical withdrawal symptoms of nicotine. 
Bupropion hydrochloride, a commonly used anti-depressant in smoking cessation, inhibits 
the reuptake of serotonin, noradrenaline and dopamine and is a nicotine receptor antagonist, 
thus preventing nicotine from binding to these receptors (Roddy, 2004). Efficacy of anti-
depressant use in smoking cessation has been demonstrated in multiple studies, however, 
the mechanism of action is not entirely understood (Shoaib & Buhidma, 2018). 
• NAC (N-acetylcysteine) – restores glutamate levels due to increased reuptake of glutamate 
at the pre-synaptic receptors, which reduces drug-seeking by mediating behavioural 
sensitisation. NAC may reduce cravings and withdrawal symptoms while assisting in the 
repair of tissues that were damaged by cigarette smoking. It protects cells from damage 
caused by oxidative stress (Prado et al., 2015).  
• Varenicline - a pharmaceutical smoking cessation aid which reduces cigarette cravings by 
partially activating the nicotinic receptors in the brain. It blocks nicotine from binding to 
these receptors thereby eliminating the satisfaction from smoking (Martin, 2019b). 
 
2.2 Complementary Medicine 
According to the World Health Organization (WHO), Complementary Medicine (CM) “refers to a 
broad set of health care practices that are not part of that country’s own tradition or conventional 
medicine and are not fully integrated into the dominant health-care system”. In contrast, Traditional 
Medicine (TM), refers to “the sum total of the knowledge, skill, and practices based on the theories, 
beliefs, and experiences indigenous to different cultures, whether explicable or not, used in the 
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maintenance of health as well as in the prevention, diagnosis, improvement or treatment of physical 
and mental illness.” The terms complementary medicine and traditional medicine are used 
interchangeably in some countries. Complementary medicines may refer to products used to treat, 
while complementary therapies may include CM professions (Gower, 2017; WHO, 2019b). 
 
Of the six WHO regions, 34 Member States include herbal or traditional medicine in their national 
essential medicines lists (NEMLs), while others have lists of essential herbal medicines. In 2018, 
the WHO South-East Asia and African Regions showed that 85% of the total Member States 
reported having a national policy for TM and CM. Regions having national policies included: the 
Eastern Mediterranean Region (43%), the Western Pacific Region (63%), the European Region 
(21%) and the Americas (31%). In many Member States there is an integration of national laws 
and the regulations for TM and CM (WHO, 2019c). 
 
The types of TM and CM commonly used across Member States, from most popular to least 
popular include:  
• Acupuncture - stimulates certain bodily points, usually with a needle penetrating the skin, 
to treat health conditions. 
• Herbal Medicine – use of plant based medicines or herbal remedies for medical conditions. 
• Homeopathy - treating ailments holistically using natural substances in minute doses. 
• Traditional Chinese Medicine - includes diet, herbal therapy, meditation, physical exercise, 
and massage. 
• Naturopathy - treating or preventing disease without the use of drugs, by techniques like 
dietary control, exercise, and massage. 
• Chiropractic - diagnosing and manipulating misaligned joints and spinal column. 
• Osteopathy - treating medical disorders by manipulating and massaging the skeleton and 
musculature. 
• Ayurvedic Medicine - uses diet, herbal treatment, and yogic breathing to obtain balance. 
• Unani Medicine - uses lifestyle changes to treat or prevent diseases. (WHO, 2019c). 
 
Other forms of CM practices reported by Member States include: cupping, hypnosis, reiki, 
therapeutic massage, Bach flower remedies, yoga, dietary supplements, meditation, ozone therapy, 
and more. In 2018, 70 Member States reported that TM and CM practitioners require a license in 
order to practice legally and within the policies of that state. Such licenses are in the form of a 
certificate which is provided by the government of council that governs TM and CM in each 
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country. This council is often responsible for issuing professional titles for diagnosing and treating 
patients (WHO, 2019c).  
 
The WHO estimates that about 65 to 80% of the world’s population use CM as their primary form 
of healthcare. CM has been established to increase access to health care in developing countries 
where access to mainstream medicine is lacking (Zhang et al., 2014).  
 
In South Africa, the practice of CM professions is regulated by the Allied Health Professions 
Council of South Africa (AHPCSA) and includes the professions of Chiropractic, Osteopathy, 
Naturopathy, Homeopathy, Phytotherapy, Traditional Chinese Medicine and Acupuncture, 
Ayurveda, Unani-tibb, Therapeutic Aromatherapy, Therapeutic Massage Therapy and Therapeutic 
Reflexology (AHPCSA, 2018a). 
 
Phytotherapy uses extracts of plant origin (herbs) as medicines or to promote healing. 
Therapeutic Aromatherapy natural and holistic therapy using essential oils to treat the entire body 
(mind, body and spirit). Therapeutic Massage Therapy relieves pain, reduces stress, and works on 
a specific problems like injuries. Therapeutic Reflexology physical treatment promoting healing 
and wellbeing through pressure and manipulation of reflex points on the feet and hands 
(AHPCSA, 2018a). 
 
The AHPCSA is a statutory health body that provides the TM and CM licenses needed to practice. 
The AHPCSA is accountable to the Ministry of Health, while the Ministry of Health is accountable 
to the public. Professional boards are accountable to the council (AHPCSA, 2018b). The AHPCSA 
provides the scope of practice for practitioners and therapists, principles of medical ethics, duties 
and obligations of practitioners, duties of the patient, duties of colleges and other professionals, 
self-duty in accordance with knowledge, skills and professionalism, and duties to society, 
environment and profession. They provide regulations, guidelines and policies regarding each 
profession as described to be included under the AHPCSA (AHPCSA, 2015a).  
 
The council’s objectives are to assist in protecting and promoting the health of the community. 
They control how the professions practice and investigate any complaints against practitioners. 
They ensure that the correct training has been completed by the practitioner before they register to 
legally practice their profession. Council advises and communicates with the Minister as required 
and deemed necessary (AHPCSA, 2015b).  
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According to the General Regulations made in terms of the Medicines and Related Substances Act 
of 1965 (Act 101 of  1965), a medicine categorised as a CM includes any substance or combination 
thereof, that originates from minerals, animals, plants, algae, lichens, fungi, seaweeds, or other 
substances as determined by the Authority. It may be used to maintain, complement or assist the 
physical or mental state, or diagnose, treat, mitigate, modify, alleviate or prevent disease or illness 
or the symptoms, or signs thereof, or abnormal mental or physical state of an animal or human 
being. A CM may include a substance used in accordance with any of the disciplines identified by 
the South African Health Products Regulatory Authority (SAHPRA) or may be used as a health 
supplement (Department of Health, 2017). 
 
SAHPRA was formed by the government to oversee regulation of medical devices, medicines, 
CMs, diagnostic tests and devices, devices used in health care and industry and radiation emitting 
products. The Medicines Control Council (MCC) and Directorate of Radiation Control (DRC) have 
been replaced by SAHPRA. Public health and safety are part of the duties SAHPRA is responsible 
for (SAHPRA, 2019).  
 
2.2.1 CM in the cessation of smoking 
There are various CM practices and medicines that are proposed to aid in smoking cessation. Less 
popular methods of CM types for smoking cessation include deep breathing, exercise, relaxation 
methods, meditation, massage therapy, yoga and healthy habit creation. Drinking an increased 
water volume is promoted to assist with the process of cessation as it is suggested to aid 
“detoxification” (Martin, 2019a). The most popularly used CM types include acupuncture, 
homeopathic remedies and herbal medicine. Additional to these, hypnosis, exercise, diet and 
supplements such as gamma-aminobutyric acid (GABA) and NAC are commonly used alternative 
approaches which assist in cessation (Burklund, 2019; Wong, 2019). 
 
GABA is an inhibitory neurotransmitter which is involved in the reward processes in the central 
nervous system. Activation of GABA receptors leads to decreased reinforcement of nicotine, thus 
reducing the rewarding effects of smoking and assisting in smoking cessation (Markou, Semenova 
and Paterson, 2006). Castor oil has been known for its anti-inflammatory and detoxifying 
properties. Castor oil is rich in ricinoleic acid and several other fatty acids, which are intestinal 
peristalsis stimulants. It is used orally and as a topical treatment over the liver and lungs (Burklund 




Acupuncture involves applying needles to specific acupressure points of the body. Auricular points 
are most commonly used in smoking cessation treatment. The best outcomes of cessation are found 
when acupuncture is used in combination with counselling. A similar effect in smoking cessation 
can be found from Nicotine Replacement Therapies (NRT). Acupuncture may contribute to 
reducing personal and public health burdens caused by smoking (Wang, 2019). 
 
Acupuncture has shown to be effective in aiding in smoking cessation because of its use in treating 
and reducing withdrawal symptoms from multiple substances. It assists in reducing cigarette 
cravings and other withdrawal symptoms during a quit attempt and it increases success in long term 
cigarette smoking cessation. The acupuncture pressure points used include: points on the wrist, 
kidney, liver, lung as well as sympathetic auricular points (Bier et al., 2011). 
 
A study on acupuncture and smoking cessation was conducted over 4 weeks with 5 treatments per 
week. Follow ups were conducted after each session in the treatment period, as well as every 3 
months after the treatment period. Half of the participants had maintained smoking cessation after 
18 months and the other half had decreased their frequency of smoking. It must be noted however, 
that acupuncture is most effective in smoking cessation, when used in conjunction with education 
and other therapies including behavioural training, relapse prevention and social support, as 
assessed during the study (Bier et al., 2011).  
 
2.2.1.2 Homeopathy 
Homeopathic remedies are used to treat the physical, mental and emotional aspects of a person. 
There are several homeopathic remedies providing clinical evidence in aiding smoking cessation 
according to DrVictor Tsan, a homeopathy practitioner at the Philadelphia Quit Smoking Center. 
These are most effective when the case is appropriately managed by the homeopath, so that the 
correct remedy is used at each phase of quitting and abstinence. The four most common remedies 
used in clinical practice in smoking cessation are:  
• Plantago major – commonly known as plantain, is used during nicotine withdrawal and 
imitates tobacco aversion in the smoker. Indications for this remedy include insomnia, 
burning eyes, constipation, sadness, bad temper and aching limbs (Tsan, 2019); 
• Tabacum – also known as tobacco, is another remedy used to assist smoking cessation. 
Tabacum is effective in decreasing cigarette cravings. Indications for this remedy include 
sudden, watery diarrhoea, motion sickness, incessant nausea, vomiting on least motion, cold 
sweats, inattentiveness and confusion and hypertension (Tsan, 2019); 
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• Ignatia amara – also known as the St. Ignatius bean, is indicated when there are extreme 
feelings of anxiety with cravings and hypersensitivity with moodiness, which are seen 
during nicotine withdrawal. Other indicatory symptoms include melancholy, dry cough, 
neck and back pain and migraines. These are often worse in the morning and are hardly 
present at night (Tsan, 2019); and  
• Lobelia inflata – commonly known as garden lobelia or Indian tobacco (Lobeline). Lobelia 
is used in potency in clinical practice to aid in smoking cessation as it is said to increase 
dopamine levels in the brain like nicotine does, therefore when the remedy is used during a 
craving, there is still a dopamine response and thus no need for the cigarette (Tsan, 2019; 
Wong, 2020). 
 
An article written by Schueller (1997), states through his clinical experience, that a complex of 
specific homeopathic remedies are effective in increasing will power to quit smoking, reduce 
nicotine cravings and decrease withdrawal symptoms. The remedy complex includes Nux vomica, 
Lobelia inflata, Tabacum and Staphysagria canadensis. It was evident through the use of this 
complex with his own patients, that it assisted in treating a broad set of symptoms and could be 
used among many smokers who attempt to quit smoking. This form of complementary treatment 
for smoking cessation is appealing because there is no risk of toxicity or side effects because 
homeopathy is non-toxic. He says that in conjunction with various strategies and methods, 
homeopathy works well in assisting smokers to quit and remain abstinent. 
 
Bala and Srivastava (2020) wrote an article on the Role of Homeopathy in Tobacco Addiction. It 
addresses the the use of homeopathy in tobacco addiction and withdrawal. Remedies regarding the 
effects of tobacco, tobacco cravings and withdrawal symptoms. The main remedies researched 
were Nux vomica, Ipecacuanha, Plantago major and Avena sativa. The indications for these 
remedies were researched and their effectiveness. Bala and Srivastava concluded that homeopathy 
should be included in tobacco cessation treatments, due to the effectiveness of the remedies and 
lack of side effects.  
 
A study done in India (2019) examined the effectiveness of Plantago major in tobacco cravings. 
30 patients from both genders between 15 and 30 years of age were observed. They completed 
surveys before the 4-week study began and once the study was completed. Plantago major was 
given in 12C, 30C or 200C based on the susceptibility of the patient with relation to physical 
activity and skill, intellect and general personality respectively. The Fagerstorm Tolerance Scale 
was used to measure the level of tobacco dependence of each participant every 2 weeks to 
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determine whether the treatment was effective or not. 27 of the participants had marked decreases 
in tobacco dependence and cravings at the end of the study. The study concluded that homeopathy 
is effective in treating patients to assist in smoking cessation, as each potency of the remedy used, 
helped to decrease tobacco dependence (Shukla, 2019).  
 
2.2.1.3 Herbal medicine  
Herbal medicine is a form of medicine which uses roots, leaves, stems, seeds or flowers of plants 
to assist in disease prevention, the treatment of illnesses and improvement of general health (NIH, 
2020b). It is a popular CM for both acute and chronic disease. The most popular herbal medicines 
for smoking cessation include: 
• Lobelia inflata – has proven to be an effective substitute for tobacco during withdrawal and 
craving symptoms. As mentioned previously, lobeline binds to the nicotinic receptors in the 
brain causing a dopamine release. Therefore, using lobelia will decrease the desire for a 
cigarette (Paddock, 2017). It is also utilised for its calming effects. It can be potentially 
toxic, therefore, small doses are recommended (Ehrlich, 2015); 
• St John’s Wort (SJW) – is popularly known for its antidepressant properties. It inhibits the 
reuptake of serotonin, dopamine and norepinephrine in the brain, making smoking less 
enjoyable, while aiding in mood support. When SJW is used during a craving, it increases 
dopamine concentration and turnover, accounting for its antidepressant properties (Nisaa et 
al., 2018); 
• Panax Ginseng – enhances energy levels and improves the stress response. It is common to 
experience anxiety and increased fatigue during a quit attempt. Ginseng is helpful in 
combating these symptoms and assists the body in dealing with withdrawals more 
effectively (Page, 2019); and 
• Valeriana officinalis – also known as Valerian, has been found to have a beneficial effect 
on insomnia, stress and anxiety. It has muscle relaxant properties and aids in easing 
restlessness. Withdrawal symptoms may include increased muscular tension and 
restlessness and Valerian administration may counteract these symptoms, assisting in a 
more successful outcome in smoking cessation (Page, 2019). 
 
2.2.1.4 Hypnosis 
During hypnosis a trance-like state is achieved through breathing and relaxation techniques. One 
is considered to be awake but the mind is disconnected, making it far more open to suggestion. 
Hypnosis allows the hypnotist to help change the way the mind reacts to certain stimuli. Hypnosis 
is proposed to control the impulses and desire to smoke, as well as increase the willpower to 
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maintain abstinence. It has been found more effective in maintaining abstinence compared to NRTs 
(Greenhalgh et al., 2016 & Smith, 2018). Smokers often smoke to reduce stress. Hypnosis can aid 
in altering the natural response to light a cigarette in those stressful situations, thereby preventing 
smoking. It may also be used to change the perception of smoking. For example, the smell of 
cigarettes may be suggested to smell like something with an unpleasant smell, thus deterring one 
from smoking. Some other suggestions repeated during hypnosis to deter one from smoking 
include: smoking is poisonous, the concept that one should protect and respect their body, or the 
concept that the body is needed in its healthiest state for life to continue. Studies have shown that 
after 6 hypnotherapy sessions, 90% of participants abstain from smoking (Smith, 2018). 
 
2.2.1.5 Exercise 
Exercise excites the reward pathways of the brain due to increased neurotransmitter activity. These 
neurotransmitters have been implicated in nicotine addiction, which is why some people become 
“addicted” to exercising. Exercise is a viable substitute for cigarettes during cravings, especially 
short bouts, while gradually increasing the duration and forming healthy and maintainable routines. 
Consistent exercise promotes other healthy lifestyle changes such as healthy diet and sleep hygiene, 
thus assisting in diminishing the desire for drug or substance use (Linke et al., 2017). 
 
Exercise aids in the management of weight gain that often accompanies smoking cessation due to 
the increase in appetite or replacement of cigarettes with unhealthy and “satisfying” foods. In 
addition, it helps one cope with nicotine withdrawal and is effective in reducing cigarette cravings, 
while being associated with higher abstinence rates due to the lowered level of depressive 
symptoms (Greenhalgh et al., 2016).  
 
Literature assessing the acute and chronic effects of exercise on mental health shows improved 
mental and emotional well-being. Mental health is relevant to smoking as smokers are often in a 
state of poor mental health and insufficient physical activity, relative to their non-smoking 
counterparts. Smoking is more prevalent among those with mood disorders. Many claim to smoke 
to decrease depressive symptoms and mood disorders in general. When exercise is used as an 
alternative to smoking during a craving, an immediate reward is offered, as the desire to smoke and 
withdrawal symptoms are all decreased. Exercise is habit-forming for some, making it easy to use 
as a smoking replacement. There are various exercises that can be done anywhere and anytime 
including walking, chair-based activities and body weight exercises. This smoking cessation tool 
is most beneficial when increasing the duration of exercise gradually (Linke et al., 2017).  
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Yoga is considered a complementary therapy and is utilised for a variety of ailments. It is beneficial 
for physical and mental health. In cases where yoga has been practised during a quit attempt, there 
has been a higher quitting success rate (Greenhalgh et al., 2016). Yoga increases the probability of 
successful abstinence from smoking, with persons doing yoga having a 12% increase in the 
probability of quitting at the end of treatment (Bock et al., 2018). Yoga leads to improvements in 
cardiopulmonary function, self-efficacy and overall well-being, while decreasing anxiety and 
stress. These effects are due to the total practice of yoga including meditation, breath work and 
physical exercise. Yoga practice leads to decreased withdrawal symptoms and cigarette cravings 
and improves the mood (Bock et al., 2012).  
 
2.2.1.6 Diet 
Food plays a role in smoking cessation because many smokers avoid cessation due to the associated 
weight gain. In addition, some foods or drinks enhance the enjoyment of smoking and may increase 
cigarette cravings, including coffee, alcohol, sweet or spicy food, and red meat. Alternatively, some 
foods and drinks do not pair well with cigarettes and potentially stop the cravings. These foods 
could be incorporated in the diet to aid smoking cessation (Migala, 2017). They include:   
 
• Milk - worsens the taste of cigarettes; 
• Fruit and vegetables - increase the likelihood of smoking abstinence by 3 times; 
• Popcorn - low in calories and helps occupy the hands and mouth; 
• Frozen grapes – for consumption during sugar cravings instead of processed and refined 
sugars. As they are frozen, they take longer to eat resulting in fewer grapes being consumed; 
• Cinnamon sticks – are pleasant to suck or chew; and 
• Beans and other high-fibre foods – aid the maintenance of healthy body weight during the 
quit attempt, as well as during abstinence once cessation has been achieved (Migala, 2017).  
 
2.2.1.7 Supplements  
There are a number of supplements recommended during cessation, as they have various benefits. 
The supplements that are most commonly recommended include: 
• Vitamin B complex – many of the B vitamins are depleted during smoking, which is why it 
is suggested to take vitamin B complex to assist in decreasing nicotine cravings as well as 
irritability. High levels of homocysteine adds to decreased cognitive function; thus leading 
to poor mental health symptoms including irritability and depression. Vitamin B assists in 
the breakdown of homocysteine. Replenishing these vitamins must be monitored and done 
correctly to prevent increasing the risk of cancer developing (Fratoni and Brandi, 2015);  
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• Vitamin C – is a vital vitamin as it assists immune function, production of collagen and cell 
repair, and reduces blood sugar levels. Vitamin C regenerates antioxidants like vitamin E. 
Having a high dietary vitamin C intake helps to decrease the risk of lung cancer in smokers 
(Martin, 2020b). This is due to the role vitamin C plays in reducing free radicals and 
oxidative damage to DNA, which blocks carcinogenesis and has chemo-preventive effects 
(Luo et al., 2014); 
• Vitamin E – is an essential vitamin for cardiovascular health. It boosts the immune system 
and increases red blood cell production. It provides antioxidant replacement for the 
antioxidants depleted during smoking (Martin, 2020b); and 
•  L-Theanine – is an amino acid which aids in stress reduction. People often smoke due to 
stress and may experience increased stress during a quit attempt. Supplementing with L-
Theanine can aid in a more successful quit attempt through the reduction of stress, leading 
to long-term cessation (Turrill, 2019). 
 
2.3 Related research 
This section discusses research studies which include various forms of CM used in cigarette 
smoking cessation. It looks at the interest of smokers using CM to quit smoking, various herbal 
products, the use of Electronic Nicotine Delivery Systems (ENDS), therapy, meditation and 
exercise to assist in smoking cessation.  
 
A survey conducted at the Nicotine Dependence Centre at the Mayo Clinic found that of 1 175 
patients from the facility who smoke, 27% used CM to stop, and a further 67% were interested in 
the future use of CM. The CMs most popularly used and perceived to be efficacious included 
meditation, relaxation, yoga and massage therapy. Levels of interest in smoking cessation by using 
CM were also classified according to the modality preferred. The modalities with the highest 
interest for future use were acupuncture, hypnosis, relaxation, herbal products and massage 
therapy. The values are therefore a direct representation of current CM use and interest in future 
use for smoking cessation (Sood et al., 2006). 
 
A pilot study assessing the efficacy of Beyond Nicotine® herbal capsules in smoking cessation was 
completed in 2015, at the University of Johannesburg on 30 participants over 31 days. All 
participants were classified as smokers. Of the 30 participants, 70% smoked between 10 and 12 
cigarettes daily and had done so for 4 to 6 years, indicating a high prevalence rate. It was determined 
that habit played a large role in smoking. Participants smoked when bored, at specific times of the 
day, as part of ritualistic behaviour and whilst driving. The study’s outcomes were largely based 
33 
on the assessment of Daily Smoking Log Sheets (DSLS) and demonstrated that the Beyond 
Nicotine® herbal capsules improved the smoking cessation rate of the group by 47%. Improvements 
were noted with regard to withdrawal symptoms, cigarette consumption and nicotine dependence. 
Due to the limited nature of the study, the results require confirmation in larger rigorous clinical 
studies (Chetty, 2015). 
 
In 2015, a survey was conducted in Canada to assess the use of smoking cessation products in 
community pharmacies. The number of “quit attempts” made by the 180 participants was noted as 
well as the attempt dates. Conventional smoking cessation products demonstrated little success in 
smoking cessation, while self-motivation was the most important factor to success in 45.5% of 
participants (Phung et al., 2017).  
 
A study done on participants from GfK’s Knowledge Panel in the USA on the use of Electronic 
Nicotine Delivery Systems (ENDS) was conducted on 1 284 smokers to assess smoking cessation 
in 2015. ENDS deliver an aerosol from a heated solution containing nicotine, glycerol, flavouring 
agents and propylene glycol, which is inhaled (Evans et al., 2014). The number of abstinent days 
was assessed along with the number of cigarettes smoked daily where abstinence was not 
maintained. The level of importance of using ENDS to aid in quitting was also assessed. Only 9.2% 
of participants reported sustained abstinence in follow up surveys done one year later. They are 
therefore not highly effective in maintaining smoking cessation, in comparison to quitting “cold 
turkey”, which had a 72.5% success rate. (Weaver et al., 2018).  
 
Saeed et al. (2019) conducted a survey to assess the efficacy of verbal behavioural therapy on 
smoking cessation. There were 3 test groups, one only underwent behavioural therapy, the second 
underwent both behavioural therapy and nicotine gum, and the third underwent behavioural therapy 
and aversion therapy using onion-powdered cigarettes. For the first group, the five A’s were used 
to assess smoking cessation, which includes: ask, advice, assess, assist and arrange. Weekly 
interviews were conducted with the second group of participants, in order to follow-up, asking the 
five A’s and to provide more nicotine gum according to the participant’s cravings. The third group 
was interviewed weekly and provided with onion-powdered cigarettes. The study found that 
behavioural therapy alone was the most effective after 6 months.  
 
In 2007, a pilot study considered the effects of stress on the rate of smoking. The study 
recommended the consideration of the use of meditation in maintaining smoking cessation as it 
was found that consistent meditation resulted in abstinence from smoking. Long term follow-ups 
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were recommended to establish the effects of meditation on abstinence, including the frequency 
and length of meditations done by participants (Davis et al., 2007). A series of randomised 
controlled trials demonstrated that meditation increases self-control, as well as aids stress 
reduction, improves attention and increases positive emotion, as a result of meditation, reduce 
cigarette cravings and the amount smoked (Tang, 2013).  
 
In a pilot study conducted in 2015, the efficacy of exercise and counselling used in smoking 
cessation was assessed. The study focused on whether or not these interventions would decrease 
depressive symptoms, increase physical activity and improve abstinence from smoking. A group 
of 70 smokers with depressive disorders had 10 sessions over 8 weeks. Aerobic exercises were held 
as a group exercise programme focused on addiction, including counselling sessions (Ninot et al., 
2015). 
 
Participants were to attend 2 group exercise classes and 2 counselling sessions for the first 2 weeks 
and 1 of each for weeks 3-8, during which they had to do 1 home-based exercise session. Group 
counselling of 40-minute sessions was focused on the physical activity and smoking cessation. 
Here exercise, cravings, withdrawals, behavioural change techniques and skills in coping and 
maintaining abstinence were discussed. Depressive symptoms were measured using 
questionnaires, physical exercise was measured using accelerometers and questionnaires, while 
abstinence was measured using logic regression and odds ratios as well as, carbon monoxide levels 
(Ninot et al., 2015).  
 
At the 12 week follow-up, 48,5% of participants remained abstinent. It was thus concluded that 
exercise and counselling yield higher continuous abstinence rates than without, highlighting that 







3.1 Study sample 
The study sample consisted of a minimum of 100 participants who were current or former smokers. 
They were recruited by advertisements that were distributed by 13 various corporate companies in 
Johannesburg, with relevant permission granted (Appendix B). Industries included financial, retail, 
transportation, entertainment and storage companies.  
 
3.1.1 Inclusion criteria  
Participants were included in the study if they: 
• were classified as a smoker or former smoker of tobacco cigarettes. 
• were between the age of 18 (legal smoking age) and 80 years old; and 
• worked or resided in Johannesburg. 
 
3.1.2 Exclusion criteria 
Participants were excluded from the study if they: 
• reported having smoked less than 100 cigarettes in their lifetime: or 
• reported not having smoked cigarettes but rather only other tobacco products, such as 
cigars, hookahs or pipes. 
 
3.2 Research design and procedure 
This research study was a descriptive study that was quantitative in nature. Quantitative design is 
best used to help gather numerical data that is analysed using statistics, which is completed on a 
larger sample group (De Klerk, 2019).  
 
The study made use of self-completed, online quantitative surveys. Objective data was collected to 
determine the use of CM to support cigarette smoking cessation in Johannesburg by smokers and 
former smokers. 
 
Each participating corporation was first emailed to obtain permission to conduct the survey within 
the corporation. Each corporation signed a permission letter (Appendix B) for surveys to be 
distributed within their corporation. An advertisement (Appendix A), an information letter 
(Appendix C), and internet link for the online consent form and survey (Appendix D & E), were 
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emailed to each corporation to forward to their staff. These emails were distributed to potential 
participants between May 2020 and July 2020, by the management of each corporation. 
 
The information letter (Appendix C) was provided with the survey and described the aims of the 
study and introduced the participant to the purpose of the study. Participants were requested to 
complete a Consent Form (Appendix D) before beginning the survey, which comprised of three 
sections containing a total of twenty-six questions. Section A consisted of demographic questions, 
as well as whether participants were smokers, former smokers or non-smokers. Section B consisted 
of questions related to smoking patterns. Section C comprised of questions regarding methods used 
to aid in smoking cessation and CM use and other therapies or tools used by smokers or former 
smokers to aid in smoking cessation. Section B and C of the survey both contained questions that 
had multiple answer choices, various scales of use, levels of awareness and effect. Some questions 
required simple yes or no answers, while others were more complex and required multiple answers 
and/or reasons.  
 
The participants were required to answer the questions by selecting the relevant answer block or 
typing their answer in the space provided. If participants selected the “other” option, they were 
required to elaborate in the comment box provided. Once the participant completed the survey, it 
was saved and submitted online.  
 
Participants could complete the 5-10 minute survey online in their own time and space. The 
researcher was available via email to offer assistance to the participants at any point. After each 
survey was completed, it was submitted online, which was secure and only accessible by the 
statistician and was relayed to the researcher.  
 
3.3 Reliability and validity measures 
The survey questions were compiled, with the aims of the study in mind, by the researcher, 
supervisor and STATKON statistician. To meet the aims of the research study, an extensive 
literature review was done to determine the types of questions that were deemed necessary to 
include in the survey. Questions from various other studies with similar aims were adapted and 
included for this study to ensure content validity. The studies utilised included Phung et al. (2017), 
Saeed, et al. (2019) and Weaver et al. (2018). Several questions were adjusted to suit the needs of 
the proposed study and add relevance to the subject matter, with a focus on CM. A statistician from 
STATKON analysed the questions further to ensure that the data would yield significant results. 
This was done by changing the length of the survey to accommodate for the survey being completed 
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by participants as far as possible, while filters were added to several questions so that participants 
would be directed to the correct set of questions, based on their responses.  
 
The researcher considered multiple factors during survey design, along with the help of the 
supervisor and statistician from STATKON. This was done to form accurate questions that would 
assist in gaining the relevant data, thereby increasing the validity of the survey. The factors 
considered include: 
• Correct structure and wording of each question to ensure clarity and that there was nothing 
misleading 
• Ensuring that all questions are pertinent to the survey and that no unnecessary questions 
were included 
• Use of an “other” option was included so that participants could specify answers that were 
not included in the options provided 
• Use of various scales to gage awareness or extent of use, providing multiple options, 
ensuring that an option could be selected 
• The use of simple, easily understood language  
• Example questions from other surveys and researchers with similar aims or objectives 
 
Validity was considered by the researcher, the supervisor and the statistician from STATKON 
during the development of the survey. Content validity was used to assess whether the questions 
asked would provide relevant and accurate data. Participation in the study was validated by the 
participants meeting the inclusion criteria. Validity of the survey was bolstered by the incorporation 
of questions from surveys sourced from peer reviewed studies on smoking cessation (Phung et al., 
2017; Saeed et al., 2019; Weaver et al., 2018). 
 
A pilot study was completed with three eligible participants prior to the study in order for the 
researcher to assess the questions and timing of the survey. Changes were made to the survey based 
on feedback from participants who took part in the pilot study. This assisted in refining the survey. 
The number of participants and/or responses from the pilot study were too small to test reliability.  
 
There are multiple benefits associated with data collection through surveys, however, some 
negative aspects exist too. Advantages of a survey include: higher response rates, cost and time 
effectiveness, larger sample groups, informational aids, convenient data capturing, respondent 
anonymity, decreased researcher bias and pre-testing of the surveys each allows precise results to 
be obtained. Disadvantages of a survey include: different interpretations of questions, a decreased 
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response rate when compared to other methods, such as in-person and telephonic surveying, 
inaccurate answers where there are not enough options available to the person, incomplete surveys 
or skipped questions, dishonest answers, unavailability to the illiterate or those with hearing or 
visual impediments (Debois, 2019). It was determined that a survey was suitable for this study as 
the advantages of the data collection method outweighed the disadvantages. 
 
3.4 Data collection and analysis 
This was of a cross-sectional, descriptive design. Data was collected using QuestionPro software, 
where participant responses were recorded. QuestionPro is an online survey tool providing a 
platform to create an online survey, which can then be sent out to participants to answer. The data 
obtained from participants is then downloaded from QuestionPro.  
 
The participants’ responses were analysed by the STATKON statistician using IBM SPSS Statistics 
version 26. This was a cross-sectional, descriptive study, where Likert-scale questions and custom 
tables were used. No Exploratory Factor Analysis (EFA) and Reliabilities were done, as answers 
were not expected to correlate.  
 
3.5 Ethical considerations 
Management of various corporate companies were approached using the Study Advertisement 
(Appendix A). Those who agreed to participate were requested to complete the Permission Letter 
(Appendix B) and were subsequently sent an email that was to be distributed to their staff. This 
email provided an information letter (Appendix C) and a link for online consent and surveying. 
The information letter was provided by management to participants prior to participation in the 
survey. Consent was required from participants prior to participation in the survey. 
 
The information letter (Appendix C) provided participants with the name of the researcher and the 
purpose and benefits of participating in the study. No direct benefits or risks were related to the 
study. If participants had any questions, they were asked to contact the researcher, whose contact 
information was made available.  
 
Anonymity was maintained as participation was anonymous with no identifying data being 
required at any time. The researcher additionally was not aware of the identity of participants. The 
storage, sharing and managing of research data remained confidential throughout. 
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The right to withdraw from the study was available until the completed survey was submitted 
online. After submission of the survey, withdrawal was not possible due to anonymity, meaning 
that the researcher could not track the specific survey for which withdrawal would be requested. 
Participation was voluntary and participants could choose to withdraw from the study without any 
negative consequence. All the completed surveys were stored safely online through QuestionPro. 
Only the STAKON statistician had access to the collected data, which was relayed to the researcher. 
The results of this study were made available to the participants on request. All surveys were 
destroyed and/or deleted after the research had been published.  
 
This study was approved by the Research Ethics Committee of the Faculty of Health Sciences, 








This chapter will present the data collected from the survey titled “A survey to determine the use 
of CM to support cessation of cigarette smoking in Johannesburg”. This will be done by means of 
tables, figures and flowcharts representing the results.  
 
The aim of the study was to determine the use of various CMs in the cessation of cigarette smoking 
in Johannesburg through online surveying of smokers and former smokers. The Nationwide 
lockdown implemented in response to COVID-19 called for the survey to become an online one 
rather than in-person, bringing new challenges forward. Online surveying was challenging, as the 
lack of in-person interactions meant not being able to answer any possible questions directly. A 
delay in survey completion was also seen, as it was easily put aside for a later time as opposed to 
in-person surveying. Despite the challenges, the survey reached the necessary number of 
participants and provided a range of both expected and thought-provoking data. The results inspired 
various data comparisons, which lead to even greater insights. 
 
4.2 Participants 
A total of 142 people participated in the survey, of which 116 surveys were completed and usable. 
The survey was conducted from June 2020 to August 2020. This research survey was a descriptive 
study where the data analysed consisted of frequencies and descriptive statistics. The survey 
included Likert-scale questions. The data results start by describing biographical information of 
the sample population before presenting cross-tabulated descriptive statistical results relating to the 
smoking patterns and methods used in cigarette smoking cessation.  
 
Emails sent to companies in Johannesburg requesting permission for their staff to participate in the 
study and providing information about the study, were sent to 80 companies, of which 42 were 
considered delivered and thus received the following email containing the link for online consent 
and surveying. Below (Figure 0.1) is a representation of recruitment for the study. This provides 
information around emails sent to the management of corporations as well as total numbers of 




Figure 0.1: Flow diagram of survey responses received 
 
4.3 Section A – Background information 
 
4.3.1 Smoking status 
Smokers and former or ex-smokers were the target group of this survey. Of the 142 participants, 
85 (59,9%) were smokers, 37 (26,1%) were former or ex-smokers and 20 (14,1%) were non-
smokers (Figure 0.2). Only the smokers and former smokers were permitted to continue with the 




Figure 0.2: Smoking status 
 
4.3.2 Age 
The minimum age for participation was 18 years old. A majority of participants were between the 
ages of 18 and 35 years (n = 68; 55,7 %) with most participants between the ages of 26-35 (n = 38; 
31,1 %). A total of 54 participants were over the age of 36 with a larger proportion (n = 26; 21,3 
%) from the category of 46 to 55 years old. Only 3 participants (2,5 %) were over the age of 65 
(Figure 0.3).  
 
 
Figure 0.3: Age 
 
4.3.3 Living and/ or working in Johannesburg  
With regard to Figure 0.4 below, representing the demographic position of the participants, 18,9% 
(n=23) only live or reside in Johannesburg, 2,5% (n=3) only work and 78,7% (n=96) both live and 































































Figure 0.4: Johannesburg residence and occupation 
 
4.3.4 Gender 
The majority of the participants, 52,5% (n=64) were female, while the remaining 46,7% (n=57) 
were male with one unanswered response to gender (Figure 0.5).  
 
 
Figure 0.5: Gender 
 
4.3.5 Highest educational qualification  
The largest groups of participants (n=88 in total) had an educational qualification level of a matric 
certificate or post matric certificate or diploma. Respectively this means that 36,1% (n=44) had 
grade 12 or matric certificate, 36,1% (n=44) had a post matric certificate or diploma, 13,1% (n=16) 
had a bachelor’s degree and 9,8% (n=12) had a post-graduate degree. Only 4,9% (n=6) had an 























































Figure 0.6: Highest level of education 
 
4.4 Section B – Smoking patterns 
 
4.4.1 Age at which smoking began 
Cigarette smoking begins from as young as 10 years old and in some cases younger, 0,8% (n=1) 
of participants said that this was the case for them. Others, 18% (n=22) began smoking between 10 
and 15 years, 58,2% (n=71) between 16 and 20 years, 17,2% (n=21) between 21 and 25 years, 
4,1% (n=5) between 26 and 30 years, 0,8% (n=1) between 31 and 35 years and 0,8% (n=1) older 
than 35 years (Figure 0.7).  
 
 




































































4.4.2 Duration of smoking 
Figure 0.8 demonstrates that the majority of smokers, 54 (44,2%) smoked for 0-10 years, while 17 
(13,9%) smoked for 11-15 years, 15 (12,3%) smoked for 16-20 years, 13 (10,7%) smoked for 21-
25 years and a large portion of participants, 23 (18,9%) smoked for more than 25 years. 
 
 
Figure 0.8: Duration of smoking 
 
4.4.3 Number of cigarettes smoked daily 
Following the duration of smoking, the number of cigarettes smoked daily by participants was 
established. 21,3% (n=26) of participants smoked less than 5 cigarettes daily, 27% (n=33) smoked 
5-10 cigarettes, 27,9% (n=34) smoked 11-15 cigarettes, 18% (n=22) smoked 16-25 cigarettes and 
5,7% (n=7) smoked more than 25 cigarettes daily (Figure 0.9). 
 
 



























































4.4.4 Health risk awareness 
In Figure 0.10 below, the levels of awareness of the health risks posed by cigarette smoking were 
assessed. The largest group of 79,5% (n=97) of participants were extremely aware of the health 
risks posed by cigarette smoking while 16,4% (n=20) were moderately aware, 3,3% (n=4) were 
somewhat aware and 0,8% (n=1) was slightly aware.  
 
 
Figure 0.10: Awareness of health risks 
 
4.4.5 Ailments caused by smoking 
Participants were asked whether they had any ailments (conditions) that they thought could have 
been caused by cigarette smoking and the largest group of 63,9% (n=78) participants said that they 
had no ailments caused by cigarette smoking, 20,5% (n=25) said they do/ did have ailments and 
15,6% (n=19) said that they were unsure (Figure 0.11). Ailments experienced by participants 
included asthma, coughing and mucous and shortness of breath. 
 
 
























































4.4.6 Nicotine dependence 
The Figure 0.12 below represents the level of nicotine dependence among participants in the study. 
15,6% (n=19) had a low dependence, while the largest group of 48,4% (n=59) had a moderate 
dependence and 35,2% (n=43) had a high dependence, with one unanswered. 
 
 
Figure 0.12: Nicotine dependence 
 
4.4.7 Time of day of cravings 
Times at which participants felt (any, the greatest, some) cravings for a cigarette were “after meals” 
(n = 74; 34,3 %) and “in the morning” (n = 63; 29,2 %). Others experienced cravings “in the 
afternoon” (n=26, 12%) and “in the evenings” (n=36, 16,7%).  
 
The least likely time for craving was “before meals” (n=8, 3,7%), while (n=5, 2,3%) participants 
stated that they had “no cravings”, while (n=8, 3,7%) selected “other” for their time of cravings 
(Figure 0.13).  
 
Of the other, 0,8% (n=1) had cravings when consuming coffee, 2,4% (n=3) craved cigarettes during 
socializing and drinking alcohol, 1,6% (n=2) had cravings during periods of stress, 0,8% (n=1) had 
































Figure 0.13: Time of day of cravings 
 
4.4.8 Quit attempts 
Participants were asked if they had made any attempts to quit smoking. The largest group of 
participants, 60,7% (n=74) said that they had made quit attempts, 16,4% (n=20) had not made any 
quit attempts, while 23% (n=28) were former smokers (Figure 0.14).  
 
 
Figure 0.14: Quit attempts 
 
4.4.9 Number of quit attempts 
This question assessed the number of quit attempts made by those who did make quit attempts and 
the number of attempts made by former smokers. The majority of participants, 84,3% (n=86) made 
between 1 and 5 quit attempts, 8,8% (n=9) made between 6 and 10 attempts, zero participants made 
between 11 and 15 attempts and 3,9% (n=4) made more than 15 attempts. Three participants did 
































































Figure 0.15: Number of quit attempts made 
 
4.4.10 Average period of abstinence from cigarette smoking  
In Figure 0.16 below, the average abstinence period of participants is represented in days, weeks, 
months and years. The majority of participants (n=36, 35,3%) were abstinent from smoking for 
months, while (n=22, 21,6%) were abstinent for years. Fewer participants (n=20, 19,6%) were 
abstinent for days, (n=19, 18,6%) were abstinent for weeks and (n=5, 4,9%) of the participants left 
this question unanswered.  
 
 
Figure 0.16: Average period of abstinence 
 
4.4.11 Reasons for quit attempts 
Of the participants, 85,3% (n=87) made quit attempts because they wanted to stop smoking, 11,8% 


























































Figure 0.17: Reason for quit attempts 
 
4.4.12 Reasons for stopping or reducing smoking 
Participants were free to provide more than one answer in response to question on their reason for 
stopping, reducing or attempting to stop smoking. Stopping or reducing for health reasons had the 
highest response of 42% (n=71), while second highest was 16% (n=27) for loved ones. Fewer 
participants, 3,6% (n=6) did so due to social pressures, 10,1% (n=17) due to premature aging, 
10,1% (n=17) for financial reasons, 10,1% (n=17) to cope better where smoking is prohibited and 
8,3% (n=14) chose “other” (Figure 0.18).  
 
Of the 14 participants who selected “other”, 2% (n=2) were due to cigarette bans during lockdown, 
7% (n=7) did so because they wanted to, and/ or due to values or morals and 5% (n=5) were due 
to pregnancy.  
 
 







































































4.4.13 Withdrawal symptoms 
Participants were asked whether or not they experienced any withdrawal symptoms during their 
period of abstinence, of which, 32,4% (n=33) said they had no withdrawal symptoms, while 64,7% 
(n=66) did experience withdrawal symptoms. Three participants did not answer this question 
(Figure 0.19).  
 
 
Figure 0.19: Withdrawal symptoms 
 
Interesting results to note, are the withdrawal symptoms experienced during a quit attempt. Of the 
participants who reported having had withdrawal symptoms, cigarette cravings were the most 
commonly experienced in 19,8% (n=54) of the participants, along with the second highest of 17,2% 
(n=47) of participants being irritable. Following these symptoms, 12,1% (n=33) experienced 
weight gain or increased appetite, 10,6% (n=29) experienced anxiety, 8,8% (n=24) had difficulty 
concentrating, 6,2% (n=17) experienced headaches, 6,2% (n=17) experienced depression, 5,9% 
(n=16) experienced coughing, 4,8% (n=13) had insomnia, 2,2% (n=6) had constipation and gas, 
1,8% (n=5) had tingling in the hands and feet, 1,8% (n=5) had nausea and abdominal cramping, 
1,5% (n=4) experienced sweating, 0,7% (n=2) had a sore throat and 0,4% (n=1) selected “other” 






























Figure 0.20: Withdrawal symptoms experienced 
 
4.4.14 Relapses occurring 
The figure below (Figure 0.21) demonstrates how many participants did or did not relapse during 
an attempt to quit smoking. The large majority of participants, (n=89, 87,3%) who were former 
smokers or those who had made quit attempts had relapsed during a quit attempt and (n=10, 9,8%) 
did not relapse.  
 
 





























































4.4.15 Reasons for relapses 
Participants were free to provide more than one answer in response to the question on their reason 
for relapsing during an attempt to quit smoking. Associating with other smokers, especially 
socially, lead to the quit attempts being unsuccessful 19,6% (n=53) of the time, with 16,6% (n=45) 
due to frequent stressful situations or encounters, 14,8% (n=40) due to alcohol consumption and 
14,8% (n=40) being unsuccessful because of cigarette cravings. For 11,8% (n=32) of participants, 
mood swings or irritability were a contributing reason, 7,4% (n=20) relapsed due to struggling to 
cope with various emotions, 5,2% (n=14) due to weight gain or increased appetite, 2,6% (n=7) 
from feeling overconfident in a quit attempt, 2,6% (n=7) due to pessimism or a negative attitude, 
1,8% (n=5) due to not getting enough sleep or rest, 1,8% (n=5) because they became isolated from 
friends and family and 1,1% (n=3) selected “other” (Figure 0.22).  
 
 
Figure 0.22: Reason for relapses 
 
4.4.16 Reasons for never having made a quit attempt 
Participants shared their reasons for never having made an attempt to quit smoking. These include: 
the concern that withdrawal symptoms may be too strong in 7,1% (n=2) participants, 17,9% (n=5) 
were fearful of weight gain, 14,3% (n=4) were due to being surrounded by smokers, 39,3% (n=11) 
didn’t see any reason to quit and 21,4% (n=6) selected “other”, of which all said that they enjoyed 





































Figure 0.23: Reasons for never making a quit attempt 
 
4.5 Section C – Methods to aid in quitting smoking 
 
4.5.1 Extent of use of smoking cessation methods 
There are various smoking cessation methods available to smokers, which are explored in this 
question, specifically with regard to the extent of use of each method. Participants were asked to 
what extent they use or had used the various methods to assist them in quitting smoking. The 
participants were provided with 16 different methods and were asked to rate the extent to which 
each was used from 1 (to no extent) to 5 (very large extent). This can be seen in the figure below 
and in Appendix F.1 (Figure 0.24).  
 
Smoking cessation methods include a vast number of products, supplements, therapies and 
techniques among others. Figure 0.24 below represents the extent to which each smoking cessation 
method included in this question was used. Many participants used these methods to no extent.  
 
Methods which were most commonly used to a small extent include training or exercise (n=17, 
18,3%), self-help materials (n=19, 20,9%) and a combination of methods, not using any 
medications (n=17, 18,5%).  
 
Training or exercise (n=21, 22,6%), finding a hobby like reading or meditating (n=19, 20,9%) and 
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Willpower was the most used smoking cessation method to a large extent (n=30, 32,6%) and a very 
large extent (n=35, 38,0%).  
 
 
Figure 0.24: Extent of use of smoking cessation methods 
 
4.5.2 Other methods used in smoking cessation  
Additional to the previously mentioned methods to aid in quitting, 17 participants used other 
methods to assist them. Of these (n=2, 2%) used Varenicline (an anti-depressant drug), (n=6, 6%) 
used self-control or willpower, (n=4, 4%) drank tea during cravings, (n=4, 4%) used alternative 
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4.5.3 Other products used in cessation and their duration of use 
Participants listed products which they had used to assist in smoking cessation and for how long 
they used these products. These are represented in the table below (Table 4.1). 
 
Table 4.1: Products used and their duration of use 
Products used Period of time of use 
Varenicline Between 4 weeks and 3 months 
Chinese Herbal products A few months 
A high fibre, vitamin and mineral complex 2 weeks 
Homeopathic anti-smoking complex 3 months 
Nicotine patches 1 month 
Sceletium 2 years 
Withania A few months 
Bupropion (an anti-depressant drug) Between 1 month and 4 months 
Alternative cigarette brands 2 years 
GABA 500mg 6 months 
A rejuvenating herbal complex More than 6 months 
Vitamin B and C A few months 
 
4.5.4 Complementary therapies used in smoking cessation 
Participants were asked how often they used each of the 12 complementary therapies listed. They 
were asked to rate the frequency from 1 (never) to 5 (every time). This can be seen in Figure 0.25 
below and Appendix F.2.  
 
The CM therapies listed were never used by participants between 87,5% and 100% of the time. 
 
Of the modalities used most, Naturopathy was used almost every time by 3,6% (n=2) and 
Chiropractic was used every time by 3,4% (n=2) of participants in a quit attempt. Homeopathy was 




Figure 0.25: Frequency of use of complementary therapies 
 
4.5.5 Effectiveness of complementary therapies used  
The effectiveness of the complementary therapy used to aid in smoking cessation is represented 
below in Appendix F.3. This rating was done on a scale of 1 (no effect) to 5 (major effect). 
 
As seen in previous questions, complementary therapy was not used to a large extent. Those who 
did use complementary therapy gave their feedback on how effective it was in their success in 
smoking cessation and the most effective modality used was Homeopathy, with 71,4% (n=5) of 
participants stating that it had a major effect. The other 28,6% (n=2) of participants who had used 
homeopathy had a neutral effect.  
 
The second most effective complementary therapy used was Chiropractic, with 33,3% (n=2) having 
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Two modalities were said to have no effect. These include: TCM (Traditional Chinese Medicine) 




Figure 0.26 Effectiveness of complementary therapies used in smoking cessation 
 
4.5.6 Likelihood of participants who have never used a form of CM to aid in quitting 
smoking to consider it for future quit attempts  
In this question, participants were asked to rate how likely they were to use CM for future quit 
attempts on a scale of 1 (very unlikely) to 5 (very likely) or 6 (they have previously used a form of 
CM to quit smoking). Of the participants 18,6% (n=19) said they were very unlikely, 9,8% (n=10) 
were unlikely, 26,5% (n=27) were neutral, 9,8% (n=10) were likely and 15,7% (n=16) were very 
likely to use CM, while 7,8% (n=8) said that they had already used CM in quit attempts (Figure 
0.27).  
 
Besides the participants who have used CM before in a quit attempt, most participants are unlikely 
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Figure 0.27: Likelihood of using CM in future quit attempts 
 
4.5.7 Reasons for being unlikely to use CM in quit attempts 
This question provides valuable information as to why participants were unlikely to use CM in quit 
attempts. The majority of participants, 37,9% (n=11) do not believe in or use CM, while 31,0% 
(n=9) did not know enough about it to use it trustingly, 6,9% (n=2) had heard negative things about 
it and 24,1% (n=7) had other reasons (Figure 0.28).  
 
The other reasons for being unlikely included the following responses:  
• “I believe that if you want to stop, you have to just throw your box of cigarettes away and 
give it up completely. I don’t believe in any medicine, patches, therapy and cutting down. 
It’s a big decision that needs to be made when you ready to stop on your own”.  
• “I felt like I did not need aid, just mind over matter, self-control”. 
• “I just decided and kept to it”. 
• “Just wanted to STOP”. 
• “Must have the will to stop, it’s all in the head”. 
• “Personally, I believe it is a mind over matter situation. If you WANT to quit, you'll put 





































Figure 0.28: Reasons for being unlikely to use CM in quit attempts 
 
4.5.8 Participation in future research 
The willingness to consider participation in future research by participants is displayed in Figure 
0.29 below. Of the participants 69,6% (n=71) said that they would consider it and 18,6% (n=19) 
indicated at the time of answering, that they would not participate in research regarding CM and 
cigarette smoking cessation.  
 
 
Figure 0.29: Participation in future research 
 
4.6 Data comparisons 
The following data comparisons were completed using Pearson’s Chi-Square and Cramer’s V 
cross-tabulations. When the relationship between two categorical variables needs to be explored, 
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a connection exists between two variables, by comparing the identified pattern of responses. This 
allows the researcher to assess the statistical significance of the data presented.  
 
The phi coefficient is a correlation coefficient which is used for crosstabulations of 2 by 2 tables. 
The Cramer’s V takes degrees of freedom into account and is used for larger tables (Pallant, 2007). 
 
4.6.1 Age and number of cigarettes smoked daily 
In this cross-tabulation, three variable age categories are used. Here in Figure 0.30, we can see how 
many participants smoked what number of cigarettes daily and which age groups they were in.  
 
The majority of participants 36,7% (n=11) aged 18-25 years, smoked less than 5 cigarettes daily, 
30,0% (n=9) smoked 5-10 cigarettes daily, 26,7% (n=8) smoked 11-15 cigarettes daily, 3,3% (n=1) 
smoked 16-25 cigarettes daily and 3,3% (n=1) smoked more than 25 cigarettes daily.  
 
23,7% (n=9) of the participants aged 26-35 years smoked less than 5 cigarettes daily, 34,2% (n=13) 
smoked 5-10 cigarettes daily, 28,9% (n=11) smoked 11-15 cigarettes daily, 10,5% (n=4) smoked 
16-25 cigarettes daily and 2,6% (n=1) smoked more than 25 cigarettes daily.  
 
Of the participants older than 35 years, 11,1% (n=6) smoked less than 5 cigarettes daily, 20,4% 
(n=11) smoked 5-10 cigarettes daily, 27,8% (n=15) smoked 11-15 cigarettes daily, 31,5% (n=17) 
smoked 16-25 cigarettes daily and 9,3% (n=5) smoked more than 25 cigarettes daily (Figure 4.28).  
 
This is represented further by the Pearson Chi-square, with a value of 20.102 and where the 
Asymptotic significance of 0,010 is less than 0,05, making it a significant value. With 3 cells 
(20,0%) having an expected count less than 5, a Cramer’s V cross-tabulation was conducted, 
providing a value of 0,287. A medium effect is thus shown between age and number of cigarettes 
smoked daily.  
 
As seen in the Figure 0.30 below, paying special attention the largest group of participants who 
smoked the two highest amounts, between 16 and 25 cigarettes daily and more than 25 cigarettes 
daily, were older than 35 years. While the largest group who smoked less than 5 cigarettes daily, 




Figure 0.30: Average number of cigarettes smoked daily related to age 
 
4.6.2 Smoking status and reasons for stopping or reducing smoking  
This cross-tabulation includes two categories, including smokers and former smokers. The reasons 
related to stopping or reducing cigarette smoking were compared between the two categories to 
gauge if either had higher impacts on these categories.  
 
As represented in Figure 0.31, of the smokers, 37,5% (n=39) stopped or reduced the amount 
smoked due to health reasons, 16,3% (n=17) did so for loved ones, 4,8% (n=5) due to social 
pressures, 9,6% (n=10) due to premature aging, 11,5% (n=12) due to financial reasons and 10,6% 
(n=11) did so to cope better where smoking is prohibited.  
 
When looking at those who are former smokers, 49,2% (n=32) stopped or reduced the amount 
smoked due to health reasons, 15,4% (n=10) did so for loved ones, 1,5% (n=1) due to social 
pressures, 10,8% (n=7) due to premature aging, 7,7% (n=5) due to financial reasons and 9,2% 
(n=6) did so to cope better where smoking is prohibited. 
 
The biggest similarity presented between smokers and former smokers’ reasons for stopping or 
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both smokers and former smokers. Smokers stopped or reduced due to financial reasons third, while 
former smokers did so due to premature aging.  
 
 
Figure 0.31: Smoking status and reasons for stopping or reducing smoking 
 
4.6.3 Nicotine dependence and number of quit attempts made 
The results showed that nicotine dependence contributes to many factors of cigarette smoking, the 
amount smoked, how frequently, as well as considerations toward any quit attempts. Two 
categories were thus used in this cross-tabulation to determine whether there is a relationship 
between nicotine dependence and the number of quit attempts made, or not, and what that 
relationship might be.  
 
Moderate and high nicotine dependence was compared to the number of quit attempts made by the 
participants from each category. As demonstrated in Figure 0.32, of the smokers with a moderate 
nicotine dependence, the majority of 88,2% (n=45) of participants made 1-5 quit attempts, 7,8% 
(n=4) made 6-10 attempts and 3,9% (n=2) made more than 15 attempts. Of the smokers with a high 
nicotine dependence, 87,1% (n=27) made 1-5 quit attempts, 12,9% (n=4) made 6-10 attempts and 
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With the use of two categories, a Pearson Chi-Square test was done, providing a value of 1.725 and 
an Asymptotic Significance of 0,422 which is greater than 0,05 suggesting that there is no 
significant difference between nicotine dependence and the number of quit attempts made with 
regard to participants. This was therefore recoded in the Fisher’s Exact Test, providing an Exact 
Sig. of 1,000. 1 cell (25,0%) had an expected count less than 5. This indicates that the research 
participants correlate with other participants in this study, but it is not statistically generalisable to 
the rest of the population as a trend.  
 
 
Figure 0.32: Nicotine dependence and quit attempts made 
 
4.6.4 Nicotine dependence and abstinence periods 
This comparison assesses the relationship between nicotine dependence and the periods of 
abstinence maintained during a quit attempt. In this cross-tabulation, two categories were used.  
 
Participants with a moderate nicotine dependence 16,0% (n=8) were abstinent for days, 20,0% 
(n=10) were abstinent for weeks, 42,0% (n=21) were abstinent for months and 22,0% (n=11) were 
abstinent for years. Of those with a high nicotine dependence, 36,7% (n=11) were abstinent for 
days, 23,3% (n=7) were abstinent for weeks, 26,7% (n=8) were abstinent for months and 13,3% 
(n=4) were abstinent for years.  
 
This resulted in a Pearson Chi-Square being used which provided data which is not statistically 
generalisable to the rest of the population as a trend. Recoding was therefore done using the Fisher’s 
Exact Test. The Phi coefficient was done nominal by nominal; thus, the Cramer’s V value is 0,234, 
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The tests conducted indicate that higher nicotine dependence rates are associated with poorer 
abstinence rates during a quit attempt. Thus, the direction expected is true. The recoded data is 
represented in Figure 0.33 below, where smokers with a moderate dependence 36% (n=18) were 
abstinent for days to weeks and 64% (n=32) for months to years, while of those with a high nicotine 
dependence 60% (n=18) were abstinent for days to weeks and 40% (n=12) were abstinent for 
months to years. 
 
 
Figure 0.33: Nicotine dependence and abstinence periods 
 
4.6.5 Withdrawal symptoms and the extent of use of smoking cessation methods 
 
4.6.5.1 Training or exercise 
As seen above, this method used in quit attempts was most widely used from small to large extents. 
Thus, comparing the extent at which participants used training or exercise during a quit attempt 
with their experience of withdrawal symptoms was recorded.  
 
Of the participants who used training or exercise to a large or very large extent, 12,9% (n=4) did 
not have withdrawal symptoms and 25,8% (n=16) did experience withdrawal symptoms.  
 
This data provided by the Pearson Chi-Square was not statistically generalisable as a pattern to the 
rest of the population, regarding the difference between the use of training or exercise and the 
experience of withdrawal symptoms during a quit attempt. The data is represented in the Figure 
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Figure 0.34: Withdrawal symptoms experienced with regard to the extent of use of training 
or exercise during a quit attempt 
 
4.6.5.2 Self-help materials and finding a positive hobby 
The comparison between withdrawal symptoms experienced and the extent of use of self-help 
materials warrant no points of discussion in this study. There was no significant statistical 
difference and thus, it has no effect on conclusions. The same can be noted for the extent of use of 
positive hobbies like reading or meditating.  
 
4.6.5.3 Non-nicotine medications 
Non-nicotine medications were used by 25,4% (n=15) of participants who experienced withdrawal 
symptoms to a small or moderate extent and by 3,2% (n=1) of participants who did not experience 
withdrawal symptoms. The majority of participants did, however, use this method to no extent 
during a quit attempt. This data is represented in the Figure 0.35 below. 
 
After completing a Pearson Chi-Square, the Phi coefficient was done nominal by nominal; 
providing the Cramer’s V value of 0,287, which is statistically significant. Non-nicotine 
medications were thus used to a larger extent by those who did experience withdrawal symptoms 
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Figure 0.35: Extent of use of non-nicotine medications during a quit attempt with regard to 
withdrawal symptoms experienced 
 
4.6.5.4 Willpower  
As shown previously, willpower was one of the most used methods in an attempt to quit smoking. 
With relation to withdrawal symptoms experienced, there is no generalizable pattern between the 
two. Willpower was used to a large or very large extent among smokers whether they experienced 
withdrawal symptoms or not. This is represented in the Figure 0.36 below. 
 
 
Figure 0.36: Extent of use of willpower during a quit attempt with regard to withdrawal 
symptoms experienced 
 
4.6.5.5 Conventional methods 
When considering the comparison between the extent of use of conventional methods in a quit 
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conventional methods to no extent for the majority of cases. However, a difference in use can be 
seen where it was used to a larger extent by participants who did experience withdrawal symptoms 
(n=6, 10,2%), more so than those who did not experience withdrawal symptoms (n=1, 3,3%). This 
method was used to a small or moderate extent by 11 (18,6% and 36,7% respectively) participants 
of each category (withdrawal symptoms and no withdrawal symptoms).  
 
A Pearson Chi-Square was conducted due to small margins of variance between the compared 
categories. There is thus no generalizable trend to the rest of the population. This data is represented 
below (Figure 0.37). 
 
 
Figure 0.37: The extent of use of conventional methods during a quit attempt regarding 
withdrawal symptoms experienced 
 
4.6.5.6 Nicotine patches, Nicorette’s, Anti-depressants, GABA, NAC and castor oil 
Nicotine patches among the other products mentioned, were used most by participants who did 
experience withdrawal symptoms. 23,7% (n=14) used them to a small to moderate extent and 
13,6% (n=8) used them to a large to very large extent. 6,5% (n=2) of the participants who did not 
experience withdrawal symptoms used these products to a small or moderate extent and 9,7% (n=3) 
used it to a large or very large extent.  
 
A Pearson Chi-Square provided a non-generalizable data set. Although there is no pattern 
witnessed between the two groups and their use of these supplements, those with increased 
withdrawal symptoms may use these supplements or other methods more than those who did not 
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Figure 0.38: The extent of use of nicotine patches, Nicorette’s, anti-depressants, GABA, NAC 
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5.1 Introduction  
The aim of the study was to determine the use of various CMs in the cessation of cigarette smoking 
in corporate institutions in Johannesburg of smokers and former smokers. The aim was evaluated 
by means of an online survey. The data was captured online using QuestionPro software and 
analysed by the statistician at STATKON, UJ, and is graphically presented. In this chapter, the 
results from Chapter 4 will be discussed with reference to potentially influential factors regarding 
other research compared to the evaluations of this study and the conduct of the study, to gain further 
insight into the relationships present.  
 
5.2 Background information and demographics 
Background information was analyzed to determine the demographics of the population of smokers 
and former smokers in Johannesburg South Africa.  
 
5.2.1 Smoker or former smoker 
In this study, the majority of participants (n = 85, 59,9 %) were smokers, while a small group (n = 
37, 26,1 %) were former smokers. This provides data from those who have had successful quit 
attempts, as well as those who may or may not have made any quit attempts previously, with less 
success.  
 
5.2.2 Age of participants 
Regarding the age of the participants, the results demonstrated that a larger percentage of 
participants were younger, between 18 and 35 years old (n = 68; 55,7 %). With most of the 
participants being 26 to 35 years old (n = 38; 31,1 %). Based on other statistics, it would have been 
expected for participants to be in their 30s or older in age. Participants from this study demonstrate 
a group which may be more comfortable with technology to successfully participate in an online 
survey. The group in which smoking is most prevalent is largely a class of working-age 
participants. This may indicate higher stress levels regarding financial responsibilities for example. 
Participants within this age group may potentially have had more interest in the survey as they are 
somewhat more experienced smokers as opposed to younger smoking age groups. This group is 
thus more likely to possibly have made previous quit attempts. 
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5.2.3 Area of residence 
The survey included participants who only live, only work or live and work in Johannesburg, of 
which 78,7 % (n = 96) both live and work in the city.  
 
5.2.4 Sex of participants 
Of the 16,5 % of the population in South Africa who are smokers, 29 % of all males are smokers, 
and 7 % of all females are smokers (Jacob, 2018; Rataemane, 2019; Reddy, 2018). There were 122 
participants contributing to data of which, 46,7 % (n = 57) were male and 52,5 % (n = 64) were 
female. This is not consistent with the distribution of gender across the population of smokers with 
relation to literature, as it mentions that men are four times more likely to smoke than women are. 
The corporate institutions whose employees participated in this study, could potentially have had 
more female employees, or that the female employees had a greater interest in participating in the 
survey than their male counterparts.  
 
5.2.5 Education of participants 
Educational levels of participants were captured and showed that the large majority of participants 
had a matric certificate (n=44; 36,1 %) or a higher level of education (n=72; 59 %). This could be 
expected due to having employment in a corporate environment in the city and having access to 
technology, with literacy.  
 
5.3 Smoking patterns 
 
5.3.1 Age at which smoking began 
Participant responses demonstrated that the incidence of smoking occurs from younger than 10 
years of age. The highest incidence of cigarette smoking began between 16 and 20 years of age, 
with 58,2 % (n = 71) of participants having started smoking in their later teenage years. Very few 
participants began smoking after the age of 25. Beginning smoking at this age is consistent with 
research citing the average age of smoking starting, in South Africa, at 15 years and older 
(Rataemane, 2019; Reddy, 2018).  
 
The types of smokers typically found in this age range include the social, sneaky and rebel smokers 
(Jozsef Wolfe, 2013). These types of smokers may represent reasons for smoking commencing at 
such young ages. Reasons behind this could include peer pressure, as an act of rebellion toward 
authoritative figures, some may start smoking due to smoking being seen as a trend, following 
cultures portrayed on various media platforms, as well as the example set by parents or “examples” 
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that surround these younger people, leading to influence their decisions regarding cigarette 
smoking.  
 
5.3.2 Duration of smoking 
The results reflect that the majority of participants, 54 (44,2 %) smoked for 0 to 10 years, while the 
remaining 68 (55,8 %) participants smoked for a period of 11 to more than 25 years. A high 
proportion of new smokers, those having smoked for between 0 and 10 years, correlates with 
younger age, while those who have smoked for more than 25 years would likely be older in age. 
This relationship may be due to younger smokers having had fewer years to smoke as opposed to 
older smokers.  
 
This data is consistent with research which shows most female smokers in South Africa being 
between 55 and 64 years old and most male smokers being between 45 and 54 years old, which 
demonstrates that the results obtained are a fairly accurate representation of the population 
(Lehohla, 2018).  
 
5.3.3 Number of cigarettes smoked daily 
The majority of smokers, 54,9 % (n = 67) smoked 5 to 15 cigarettes daily. According to Lehohla, 
in 2018, based on the number of cigarettes smoked annually by the estimated 7 million smokers in 
South Africa, that would provide a value of 9,25 cigarettes smoked daily per smoker. This 
correlates with the second-highest category of 5 to 10 cigarettes smoked daily by participants, with 
the highest category of 11 to 15 cigarettes smoked daily, barely edging out this category, by only 
one participant.  
 
If we consider the relationship of the type of smoker and the number smoked daily, it can be noted 
that social smoking may occur frequently with a large percentage of participants smoking fewer 
than 5 cigarettes daily.  
 
5.3.4 Health risk awareness 
Awareness of the health risks that cigarette smoking poses on smokers and even non-smokers is of 
high importance, as one could argue that “they did not know the risks” or perhaps that the “risks 
were not enough to cause for concern”. However, 79,5 % (n = 97) of participants were extremely 
aware of the health risks posed by cigarette smoking. This is represented in Figure 4.10. This level 
of awareness is expected as it is assumed that based on the warnings provided, such as messages 
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provided on cigarette packaging and other warnings alike, that smokers are aware of the health 
implications of cigarette smoking.  
 
5.3.5 Ailments caused by smoking 
The results of this study showed that 63,9 % (n = 78) of participants said that they had no ailments 
or conditions caused by cigarette smoking. The remaining 36,1% (n=44) either experienced 
ailments from smoking or were unsure if smoking was the cause of any of their ailments. Ailments 
experienced by participants included asthma, coughing and mucous and shortness of breath. 
 
5.3.6 Nicotine dependence 
Considering the addictive properties of nicotine, dependence plays a big role in the reasons why 
smokers may continue to smoke or struggle during quit attempts. The nicotine dependence among 
participants was 15,6 % (n = 19) with a low dependence, the largest group of 48,4 % (n = 59) had 
a moderate dependence and 35,2 % (n = 43) had a high dependence. Reasons for the varying levels 
of dependence as indicated by the research can be as a result of cigarette types, the amount smoked 
daily and factors alike (Benowitz et al., 2013; CDC, 2010). Those with a higher nicotine 
dependence make more quit attempts than smokers who are less dependent, while a higher 
dependence results in fewer successful quit attempts which result in abstinence. Smokers who 
smoked fewer cigarettes in their lives, maintained abstinence, as opposed to smokers who smoked 
more cigarettes in their lives (John et al., 2004).  
 
A relationship can also be seen with respect to mood. Nicotine causes the release of dopamine, 
serotonin and other neurotransmitters, activating the brain’s reward centre, leading to mood 
enhancement (Widysanto et al., 2020). A relationship may be witnessed here, as with mood 
disorders like anxiety or depression, for example, the desire for euphoria and pleasure enhancement 
may be increased (IPRC, n.d.). When one has a dependence, any abstinence may lead to withdrawal 
symptoms, which would lead one to seek stimuli that result in a dopamine release, such as smoking, 
which reduces such withdrawal symptoms and reinforces the habit (Mental Health Foundation, 
2016).  
 
5.3.7 Time of day of cravings 
Participants were asked at which time they felt (any, the greatest, some) cravings for a cigarette. 
The most common times that cravings were experienced to less common, was after meals (n = 74; 
34,3 %), in the morning (n = 63; 29,2 %) and in the evening respectively (n=36, 16,7%). These 
times may trigger cigarette cravings most commonly (Jaret & Chang, 2011).  
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5.3.8 Quit attempts and the number of attempts made 
Of the participants in this study, the majority 83,7 % (n = 102) of participants had made quit 
attempts previously or were former smokers, of which 84,3 % (n = 86) made between 1 and 5 quit 
attempts, while 12,7 % (n = 13) had made between 6 and 15 quit attempts.  
 
5.3.9 Average period of abstinence from cigarette smoking  
The results showed that a small group of participants (n = 39, 38,2 %) were abstinent for days to 
weeks, while a large group of participants (n = 58, 56,9 %) were abstinent for months to years. This 
is consistent with research showing that success in continuous abstinence is seen specifically 
between 3- and 6-month abstinence periods (Gilpin et al., 1997). 
 
5.3.10 Reasons for quit attempts and stopping or reducing smoking 
Participants were asked what their reason for making any quit attempts was. The majority of 
participants made quit attempts because they wanted to stop smoking. The distribution of data 
demonstrates the reasons why smokers wanted to stop or reduce the amount smoked. The most 
commonly given motive was for health reasons (n = 71, 42 %), while second highest was (n = 27, 
16 %) for loved ones.  
 
Other reasons provided for stopping or reducing include premature ageing, financial reasons and 
to cope better where smoking is prohibited. These correspond to the literature in Chapter 2 
regarding the cost of smoking on society, the economy and the environment, as well as the smoker 
and those around them (Brown, 2015; Perucic, 2016; Swedish, 2019). These costs may not 
necessarily be financial in nature only, but physical, mental, emotional and to areas already 
mentioned.  
 
Research done in 2013 reported that 43,2% of former smokers quit due to their current health status, 
31,9% were to avoid future health implications, indicating quitting for health reasons to be 75,1%, 
with only 10,3% being for loved ones (Gallus et al., 2013). This indicates that health reasons remain 
the biggest reason for smokers quitting. 
 
Observing reasons for ones quit attempts provides insight into possible means of assisting smoking 
cessation. This could demonstrate that smokers may have begun to experience ailments or 
conditions caused by cigarette smoking, or perhaps have a pre-existing condition which is being 
negatively affected or worsened by smoking, thus calling for the quit attempt due to health reasons.  
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When making a quit attempt for loved ones, it may be due to loved ones asking the smoker to quit 
for their own health, for the benefit of the loved ones involved, or other various reasons. 
 
5.3.11 Withdrawal symptoms 
As it was expected, the majority (n = 66, 64,7 %) of participants did experience withdrawal 
symptoms during an attempt to quit smoking. Some rather significant findings from this data were 
the withdrawal symptoms experienced during a quit attempt and their notable commonality to the 
symptoms experienced in mental health disorders. Cigarette cravings were an obvious symptom, 
while others like irritability, anxiety, headaches, difficulty concentrating, depression and insomnia 
cause for higher concern to seek assistance during these times.  
 
Many of the withdrawal symptoms experienced during a quit attempt correspond with those 
experienced in mental health disorders. Some participants used anti-depressant medications during 
a quit attempt. The relationship between the reason for psychiatric medications used and perhaps 
the reasons why people smoke may show significant data. 
 
Dr Sigmund Freud was a heavy smoker who made multiple attempts to quit smoking, however, he 
was unsuccessful in remaining abstinent, saying that “subsequent depression and other withdrawal 
symptoms proved unbearable” and “the torture being beyond human power to bear”. He died of 
cancer at the age of 83, making him “the tragic prototype of tobacco addiction” (Brecher, 1972). 
 
Nicotine decreases appetite, irritability and depression while generating a sense of well-being, 
increasing concentration and mood. This occurs due to the effects of nicotine on the brain during 
cigarette smoking. Withdrawal symptoms thus include the opposite symptoms to those experienced 
during smoking, as well as symptoms of physical withdrawal. Depressive episode relapse may be 
experienced during an attempt to quit smoking. The same is true for bipolar disorder, (Burke and 
Gotter, 2018). Physical withdrawal symptoms are the first to go away, leaving mental and 
emotional symptoms behind for a while longer (Felson, 2019). 
 
5.3.12 Relapses and the reasons behind them 
A large group (n = 89, 87,3 %) of participants stated that they had experienced at least one relapse 
during their attempt to quit smoking. Various reasons leading to relapses occurring were provided 
by participants. Emotions and poorer mental health states contributed to a large portion of 
participants lack in successful cessation. The most common reasons provided were association with 
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other smokers and consuming alcohol, stress, mood swings or irritability and struggling to cope 
with various emotions among other reasons. 
 
A study showed that the reasons for relapse were due to stress and the desire for a cigarette in order 
to decrease the stress felt and to experience the pleasure associated with cigarette smoking that they 
had not experienced during the quit attempt (Buczkowski et al., 2014).  
 
5.3.13 Reasons for never having made a quit attempt 
The reasons why participants may never have made any previous quit attempts were recorded. 
Most of the participants stated at the time of questioning, that they did not see any valid reason to 
quit. The next highest reason was indicated as “other”, which included smoking due to the 
enjoyment of it or due to stressful circumstances and lifestyles. None of these reasons was actually 
preventing smokers from making quit attempts.  
 
According to Asharani et al. (2020), the main reasons why smokers do not make attempts to cease 
smoking are: the smokers enjoy smoking, withdrawal symptoms were too daunting and that they 
did not experience any health-related concerns due to cigarette smoking.  
 
5.4 Methods to aid in quitting smoking 
 
5.4.1 Extent of use of smoking cessation methods 
Participants were asked to rate the extent to which they used various smoking cessation methods. 
The majority of the methods listed were used to no extent. With this being said, many participants 
had not heard of several of these methods being used to aid in smoking cessation. 
 
Willpower was the most used method. However, according to the literature, the preferred methods 
used were anti-depressant medications and nicotine replacement therapies, among various CM 
therapies, which does not correlate with the results that show that willpower was the most used 
cessation method to a large extent (Martin, 2019b; Molyneux, 2004). 
 
Saeed et al. conducted a survey in 2019 on verbal behavioural therapy. The 3 groups in the study 
were evaluated and it was concluded that behavioural therapy alone was the most effective in 
smoking cessation after 6 months (Saeed et al., 2019). Ninot et al. (2015) assessed the efficacy of 
exercise and counselling as methods to assist smoking cessation and found that 48,5% of 
participants remained abstinent at the 12-week follow-up, highlighting that depressive disorders 
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should be treated alongside smoking cessation attempts. These modalities which have been proven 
to have positive effects are, however, the modalities which are used to no extent by participants, 
the majority of the time. 
 
5.4.2 Other methods used in smoking cessation and their duration of use 
Other methods used in quit attempts include willpower, anti-depressant medications, drinking tea 
during a craving and alternative smoking substances or workshops. These various products used 
including herbs and vitamin and mineral complexes were used by participants for periods between 
2 weeks and 2 years. Smokers are more willing to try other methods (as mentioned above) during 
quit attempts, than not, due to the frequency at which withdrawal syptoms are experienced. A trend 
can be witnessed in that many of these methods commonly used in assisting in smoking cessation, 
are often used for the treatment of mental health disorders or symptoms thereof, which can be seen 
in the literature. 
 
Herbs including Sceletium and Withania which are used for anxiety, depression, and stress 
respectively, were not those found to be used according to research done. Those found in research 
include valerian and ginseng to name a couple (Page, 2019).  
 
5.4.3 Complementary therapies used in smoking cessation and frequency of use 
Data shows that CM is not the most commonly used group of methods aiding in cigarette smoking 
cessation. The complementary therapies most used by participants were Naturopathy, Chiropractic 
and Homeopathy. A small number (n = 6, 10,7 %) of participants used Homeopathy every time 
they made a quit attempt. Studies providing data on the frequency of use of CM in smoking 
cessation are sparse, however, there are multiple sources which recommend such therapies for use 
in smoking cessation. Sasha Cain wrote an article on alternative therapies aiding in smoking 
cessation, where she states Homeopathy, Acupuncture and Osteopathy as the first therapies listed, 
followed by Chiropractic and Herbalism (Cain, 2015).  
 
5.4.4 Effectiveness of complementary therapies used  
Following on from the previous question, the effectiveness of the complementary therapies used 
was recorded. The most effective therapy used was Homeopathy and the second was Chiropractic. 
Many therapies were either not used and thus ineffective, however, those like TCM and 
Acupuncture and Acupuncture as an individual therapy were said to have no effect. It would be 
interesting to know which treatment plans were followed in each therapy and then gauge which 
could benefit future success, based on the level of effectiveness. 
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Acupuncture has been found to contribute to long term abstinence and decreased smoking 
frequencies (Wang, 2019). This does not correspond with the results of this study which 
demonstrated that Acupuncture was not effective, when the literature shows that it has in fact been 
effective in other studies.  
 
5.4.5 Likelihood of using CM to aid in future quitting attempts  
The likelihood of participants using CM in future quit attempts, excluding the participants who 
have used CM previously in a quit attempt, was unlikely or very unlikely. This presents possible 
reasons for the current lack of use of CM in smoking cessation when compared to that of 
conventional therapies.  
 
The reasons provided by participants for being unlikely to use CM include not believing in CM nor 
having used it in general, not having sufficient knowledge to use it trustingly and hearing negative 
things about CM. These reasons reveal that providing education and knowledge to the public on 
CM is vital. The other reasons provided by participants collectively stated that willpower was the 
only method that was considered to be effective and thus, there was no need to use CM in quit 
attempts. 
 
5.4.6 Participation in future research 
Results show that the majority of (n = 71, 69,6 %) participants would participate in future research. 
This corresponds with previous research, which found that 67% of participants were interested in 
future use of CM in smoking cessation attempts (Sood et al., 2006). 
 
5.5 Data comparisons  
 
5.5.1 Age and number of cigarettes smoked daily 
A pattern is presented between older age and increased number of cigarettes smoked daily. There 
may be multiple reasons for this relationship. A deeper level of addiction may also be present in 
older smokers.  
 
On average younger people smoke fewer cigarettes than older people, with those aged 18 to 35 
years smoking 16 cigarettes or less daily, while the majority of participants who were older than 
35 years, smoked 16 to 25 cigarettes daily. Research has shown that smoking more commonly 
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occurs in those older than 35 years of age (Lehohla, 2018). Further research may be viable to 
establish whether longer time periods increase ones smoking addiction or not. 
 
5.5.2 Smoking status and reasons for stopping or reducing smoking  
The results state that the reasons for stopping or reducing the amount smoked, show a correlation 
between smokers and former smokers, as both indicate that the primary reason was for health 
purposes and the second reason being for loved ones. Results demonstrate that the motives 
witnessed across both smoking statuses are along the same principles and reasoning. Research 
shows that smoker’s most common reason for quitting was due to health reasons (Uppal et al., 
2013). 
 
5.5.3 Nicotine dependence and number of quit attempts made 
In this comparison, it was revealed that the relationship between nicotine dependence and the 
number of quit attempts made, did not yield statistically generalizable results. The majority of 
participants (n = 72), irrespective of their nicotine dependence, made between 1 and 5 quit attempts, 
meaning that variations in nicotine dependence cause for no increase or decrease in the number of 
quit attempts made by smokers. As demonstrated by John et al. (2004) in a study including 4075 
participants, shows differing results, stating that those with a higher nicotine dependence make 
more quit attempts than smokers who are less dependent. This differing relationship may be 
accounted for by the larger sample of the study compared to the smaller sample size of this study.  
 
5.5.4 Nicotine dependence and abstinence periods 
The relationship between nicotine dependence and periods of abstinence during an attempt to quit 
smoking are seen. The data indicates that there is a poorer abstinence rate associated with higher 
nicotine dependence and a higher abstinence rate associated with moderate nicotine dependence. 
Smokers with a higher nicotine dependence resulting in severe withdrawal symptoms during quit 
attempts, resulted in the resumption of smoking soon after beginning their quit attempt (Tidey et 
al., 2013), thus the results of this study represent similar findings.  
 
5.5.5 Withdrawal symptoms and the extent of use of smoking cessation methods 
 
5.5.5.1 Training or exercise 
In this comparison of withdrawal symptoms experienced and the extent to which participants used 
training or exercise during a quit attempt, we can see that this method was used from a small to a 
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very large extent during quit attempts, fairly equally, by both participants who did experience 
withdrawal symptoms and by those who did not experience withdrawal symptoms.  
 
This expected data is consistent with research conducted by Ninot et al. (2015), which states that 
exercise excites the reward pathways of the brain and is thus a viable substitute for cigarettes, 
especially short bouts of exercise, while gradually increasing the duration and forming healthy and 
maintainable routines. Exercise has thus shown to decrease withdrawal symptoms experienced 
during quit attempts. 
 
5.5.5.2 Self-help materials and finding a positive hobby 
When assessing the use of self-help materials and hobbies, it can be noted that these methods were 
not used to a large extent by participants and thus no major effect was seen when used by 
participants who did experience withdrawal symptoms, or those who did not. 
 
These tools could prove a potential benefit in quit attempts if approached correctly and using 
constructive methods that engage the mind and hands, to aid in cessation (Kaplan, 2017). The 
results did not show a clear relationship; however, research suggests that these methods are useful 
in aiding in smoking cessation (Martin, 2019b). 
 
5.5.5.3 Non-nicotine medications 
Non-nicotine medications were used to a large extent by participants experiencing withdrawal 
symptoms during a quit attempt. Those who did not experience withdrawal symptoms used this 
method to a lesser extent. This is expected, as with reference to research, smokers commonly used 
non-nicotine medications in quit attempts to assist with withdrawal symptoms experienced, 
potentially due to not having had the need to use non-nicotine medications during a quit attempt, 
since no symptoms were experienced (Martin, 2019b). 
 
5.5.5.4 Willpower  
It has been made quite evident that without willpower, any quit attempt made, may not be 
successful, or that an attempt may not be made at all if the willpower to quit is not present in the 
smoker.  
 
Willpower has shown to be the most used method in smoking quit attempts. The results show that 
willpower was used equally as much by participants who experienced withdrawal symptoms and 
those who did not. According to Smith (2018), hypnosis is suggested to strengthen the willpower 
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to maintain abstinence during a quit attempt and beyond. Other tools including deep breathing, 
exercise, relaxation methods, meditation, yoga and healthy habit creation could be considered 
subcategories of willpower, as participating in these requires the use of willpower. 
 
5.5.5.5 Conventional methods  
The data represents that conventional methods were used to a larger extent by participants who did 
experience withdrawal symptoms. This is to be expected, as, with no symptoms, one would 
probably not seek additional methods to aid in their quit attempt. Conventional methods are also 
of common knowledge to many people when compared to their knowledge of CM and thus a less 
hesitant use of conventional methods is observed when the need arises (Martin, 2019b; Molyneux, 
2004).  
 
5.5.5.6 Nicotine patches, Nicorette’s, Anti-depressants, GABA, NAC and castor oil 
The use of the methods mentioned reflected that participants who did experience withdrawal 
symptoms made use of these to a larger extent than those who did not experience withdrawal 
symptoms. Although there is no pattern witnessed between the two groups and their use of these 
supplements, those with increased withdrawal symptoms may use these supplements or other 
methods more than those who did not experience withdrawal symptoms, as indicated in the 
literature (Molyneux, 2004; Shoaib & Buhidma, 2018). 
 
5.6 Limitations and assumptions  
In this discussion, a paucity of research related to CM use by smokers is reviewed. This dearth of 
knowledge makes it challenging to compare the findings on a larger scale, however, it does provide 
a showcase of what is known and not, and how this can be used to better aid smokers in their 
journey to quitting smoking.  
 
In the pilot phase of the study, participants took 5 to 10 minutes to complete the survey, however, 
in the data collection phase, it is assumed that it took longer than this time period to complete, as 
there were several incomplete questions and surveys overall. This could have been due to poor 
internet connections, the length of the survey and number of questions being time-consuming. The 
limitation of the survey being conducted online, was that the researcher was not on hand to directly 
answer any questions that the participants may have had during the completion of the survey, 
however, participants were able to email the researcher if needed. The data was captured through 
self-report and included questions regarding the age of initiation, smoking patterns and types of 
cessation methods and modalities used, which were subject to recall bias. 
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This study consisted of a small sample size, which can thus not necessarily be generalised to the 
SA or Gauteng population, but nonetheless, the study acts as an important novel research in the 
area of Johannesburg.  
 
5.7 Summary 
This chapter has emphasized that the results found were accurate concerning research done in other 
countries and at various times. A summary of the key results discussed is represented below in 
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This study set out to assess the use, knowledge and points of view of participants towards CM in 
cigarette smoking cessation. This was achieved through data collection via online surveying, where 
participants (142) were recruited via email from various corporations in Johannesburg, South 
Africa.  
 
Cigarette smoking begins at very early ages, for reasons including social acceptance and anxiety 
relief. Smokers often make multiple quit attempts during their time smoking. Participants made 
quit attempts due to health reasons and for loved ones the majority of the time. They revealed that 
the withdrawal symptoms experienced during quit attempts included cigarette cravings, anxiety, 
irritability, depression and headaches. These show a strong similarity to those symptoms 
experienced in mental health disorders.  
 
While willpower was the most used cessation method, maintaining abstinence was not always 
achievable, thus leading to the return to smoking, due to withdrawal symptoms, mood swings, 
stress and struggling to cope with various emotions. Several methods are used to aid in smoking 
cessation, one of which includes the use of anti-depressant medications. This draws attention to the 
importance of mental health disorders, due to both the symptoms it has in common with smoking 
cessation, and the treatments used for each. Coping mechanisms and lifestyle adjustments are 
needed to assist people in coping with stressors which frequently lead to cigarette smoking.  
 
The use of CM by participants during quit attempts was minimal, however, homeopathy, 
chiropractic and naturopathy were used most frequently. Homeopathy was also listed as the most 
effective CM used. The reasons provided by participants for the rarity of use of CM is partially due 
to insufficient knowledge of CM. The results of this study emphasize that stress is one of the biggest 
reasons for smoking and a consonant understanding of the reasons why smokers smoke would 
appropriately facilitate smoking cessation.  
 
Quit attempts may be associated with withdrawal symptoms, mental health challenges and lifestyle 
adjustments. CM, with little to no side effects, has the potential to support these experiences but its 
greater acceptance would likely require additional research to accurately determine the 
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effectiveness of available therapies together with education of potential users and CM practitioners 
for their best use.  
 
6.2 Recommendations 
• Data capturing should be done regularly, including a large portion of the population, to 
accurately monitor cigarette smoking in SA and each province respectively.  
• Future research on social mechanisms leading to social acceptance, which address healthier 
and more constructive social integration and ice-breakers could provide alternatives which 
decrease social anxieties and pressures that often result in cigarette smoking.  
• Education of the general public on smoking and the use of CM in smoking cessation need 
to be encouraged and implemented at all levels of schooling and other government 
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APPENDIX A  
Advertisement    
 
  
ARE YOU:  
• classified as a smoker or former smoker of tobacco cigarettes;  
(Smoker: an adult who in their lifetime has smoked 100 or more cigarettes and who currently smokes 
cigarettes OR  
Former (ex-smoker) smoker: an adult who has smoked 100 or more cigarettes in their lifetime but has quit) 
• between the age of 18 and 80 years old.  
  
If you answered YES to the above, then you may qualify to participate in a research survey 
being conducted by as student registered for studies at the  
 Department of Complementary Medicine at the University of Johannesburg.    
  
The study is entitled:  
A survey to determine the use of Complementary Medicine to support 
cessation of cigarette smoking in Johannesburg 
Ethical clearance number: REC-247-2020 
  
The survey consists of questions regarding the use of various Complementary Medicines in the 
cessation of cigarette smoking  by smokers and former smokers  
  
For more information please contact:  
Researcher’s name: HOLLY-JAY ROOTHMAN  
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APPENDIX B  
Permission Letter  
 
DEPARTMENT OF COMPLEMENTARY MEDICINE  
FACULTY OF HEALTH SCIENCES  
Telephone: (011) 559 6218  
Permission Letter 
To the manager/whom it may concern,  
My name is Holly-Jay Roothman, a Master’s Degree student in Homeopathy at the University of 
Johannesburg. I am currently working on my research study entitled, “A survey to determine the 
use of Complementary Medicine in the cessation of cigarette smoking in Johannesburg.”  
  
The aims of my research are to determine the role and use of various complementary medicines in 
the cessation of cigarette smoking in Johannesburg by way of a survey of smokers and former 
smokers. This data may potentially motivate additional research in this field on an undergraduate 
or postgraduate level. 
  
I have chosen to do a quantitative, descriptive survey to capture the data required for my study.  
  
I would like to request if I may please complete my survey (see attached) with any clients, staff or 
members at your facility/ premises?  
  
This study has been approved by the Faculty of Health Sciences Research Ethics Committee 
(Clearance number: REC-247-2020)  
  
If you have any queries about my study or the survey, please feel free to contact me and/or my 
supervisor via the details provided below:  
  
Researcher:   
Holly-Jay Roothman 082 777 8859 hollyjayroothman@gmail.com  
Supervisor:  
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Dr. N. Gower (M.Tech Hom) neilg@uj.ac.za   
  
Prof. Christopher Stein  
Tel: 011 559-6564  
Email: cstein@uj.ac.za   
  
Many thanks,   
Holly-Jay Roothman (Masters Student)  
  
Sign: _______________________        Date:_____________________  
 
Manager/whom it may concern: 
 







DEPARTMENT OF COMPLEMENTARY MEDICINE 
RESEARCH STUDY INFORMATION LETTER 
REC 11.0 
May 2020 
My name is Holly-Jay Roothman. I WOULD LIKE TO INVITE YOU TO PARTICIPATE in 
a research study on the use of complementary medicine in the cessation of cigarette smoking in 
Johannesburg. 
 
Before you decide on whether to participate, I would like to explain to you why the research is 
being done and what it will involve for you. I will go through the information letter with you 
and answer any questions you have. This should take about 10 to 20 minutes. The study is part 
of a research project being completed as a requirement for a Master’s Degree in homeopathy 
through the University of Johannesburg. 
 
THE PURPOSE OF THIS STUDY is to determine the use of Complementary Medicine, by 
current and former smokers, to aid in smoking cessation, in Johannesburg. 
 
Below, I have compiled a set of questions and answers that I believe will assist you in understanding 
the relevant details of participation in this research study. Please read through these. If you have 
any further questions I will be happy to answer them for you. 
 
1. DO I HAVE TO TAKE PART? No, you don’t have to. It is up to you to decide to participate 
in the study. I will describe the study and go through this information sheet. If you agree to take 
part, I will then ask you to sign a consent form.  
 
2. WHAT EXACTLY WILL I BE EXPECTED TO DO IF I AGREE TO PARTICIPATE? 
As a volunteer in this study, you partake in a survey of approximately 5-10 minutes, during 
which you will complete the survey regarding complementary medicine and smoking cessation. 
The survey will be completed in pen, with the researcher present. The survey will take place at 
various settings, at your free will and available time. No personal information will be disclosed 
in this study. By signing the consent form for the survey, you agree to partake in this study. 
 
3. APPROXIMATELY HOW LONG WILL MY PARTICIPATION TAKE? Your 
participation will take approximately 5-10 minutes of completing a survey. 
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4. WHAT WILL HAPPEN IF I WANT TO WITHDRAW FROM THE STUDY? If you 
decide to participate, you are free to withdraw your consent at any time without giving a reason 
and without any consequences. If you wish to withdraw your consent, you should inform me 
as soon as possible. Participants will be informed that they may withdraw their consent prior 
to submission of data without consequence, however beyond this point withdrawal of consent 
will not be possible due to the anonymous nature of the research. 
 
5. IF I CHOOSE TO PARTICIPATE, WILL THERE BE ANY EXPENSES FOR ME, OR 
PAYMENT DUE TO ME? You will not be paid to participate in this study and you will not 
bear any expenses. 
 
6. IF I CHOOSE TO PARTICIPATE, WHAT ARE THE RISKS INVOLVED? There are no 
anticipated risks. 
 
7. IF I CHOOSE TO PARTICIPATE, WHAT ARE THE BENEFITS INVOLVED? There 
are no direct benefits, however, the information derived from this study may be of value to 
smokers, former smokers and future researchers by contributing to knowledge and 
understanding of the use of Complementary Medicine. 
 
8. WILL MY PARTICIPATION IN THIS STUDY BE KEPT CONFIDENTIAL? All 
reasonable efforts will be made to keep your personal information confidential and respect your 
right to privacy. This includes replacing your identifying personal information with a number 
that only I and my research supervisor will know. You will not be identified in any research 
reports that are published. Under some circumstances, such as when required to do so by a 
court of law, I may have to disclose your personal information. In addition, it may happen that 
your information will need to be reviewed by another organisation for quality assurance 
purposes. I will tell you about this if it happens. Your completion of the study survey will be 
anonymous. 
 
9. WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? The results 
will be written into a research report that will be assessed. In some cases, results may also be 
published in a scientific journal. In either case, you will not be identifiable in any documents, 
reports or publications. You will be given access to the results of this if you would like to see 
them, by contacting me.  
 
10. WHAT WILL YOUR RESPONSIBILITIES BE, AS THE RESEARCHER? My 
responsibilities as the researcher would be to maintain my participants confidentiality and 
anonymity. I am also responsible for the authenticity of all data and the protection of the records 
that exist as a result of the study and answer any questions that you may have. 
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11. WHO IS ORGANISING AND FUNDING THIS RESEARCH STUDY?  The study is being 
organised by me, under the guidance of my research supervisor at the Department of 
Complementary Medicine at the University of Johannesburg. The research will be funded by a 
supervisor linked bursary. 
 
12. WHO HAS REVIEWED AND APPROVED THIS STUDY? Before this study was allowed 
to start, it was reviewed in order to protect your interests. This review was done first by the 
Department of Complementary Medicine, and then secondly by the Faculty of Health Sciences 
Research Ethics Committee at the University of Johannesburg. In both cases, the study was 
approved. 
 
13. WHAT IF THERE IS A PROBLEM? If you have any concerns or complaints about this 
research study, its procedures or risks and benefits, you should ask me. You should contact me 
at any time if you feel you have any concerns about being a part of this study. My contact 






You may also contact my research supervisor: 
Dr Neil Gower 
Email: neilg@uj.ac.za 
 
If you feel that any questions or complaints regarding your participation in this study have not been 
dealt with adequately, you may contact the Chairperson of the Faculty of Health Sciences Research 
Ethics Committee at the University of Johannesburg: 
 
Prof. Christopher Stein 
Tel: 011 559-6564 
Email: cstein@uj.ac.za  
 
FURTHER INFORMATION AND CONTACT DETAILS: Should you wish to have more 
specific information about this research project information, have any questions, concerns or 
complaints about this research study, its procedures, risks and benefits, you should communicate 









Research Consent Form 
 
DEPARTMENT OF COMPLEMENTARY MEDICINE 
RESEARCH CONSENT FORM 
REC 11.0 
 
THE USE OF COMPLEMENTARY MEDICINE IN THE CESSATION OF CIGARETTE 
SMOKING IN JOHANNESBURG 
Please select each box below: 
 
 
       I confirm that I have read and understand the information letter dated May 2020 for the 
above study. I have had the opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
 
 
                    I understand that my participation is voluntary and that I am free to withdraw from 
this study at any time without giving any reason and without any consequences to me. 
 
 






___________________       ________________________________  ________________ 




___________________      ________________________________ ________________ 






DEPARTMENT OF COMPLEMENTARY MEDICINE 
FACULTY OF HEALTH SCIENCES 
Telephone: (011) 559 6218 
 
PLEASE ANSWER THE FOLLOWING QUESTIONS BY SELECTING THE 
RELEVANT BLOCK OR TYPING YOUR ANSWERS IN THE SPACE PROVIDED. 
 
SURVEY 
Section A – Background information 
This section of the questionnaire refers to background or biographical information. Although we are aware of the 
sensitivity of the questions in this section, the information will allow us to compare groups of respondents. Once 
again, we assure that your responses will remain anonymous. Your co-operation is appreciated.  
 
1. Are you a:  
• (Smoker: an adult who in their lifetime has smoked 100 or more cigarettes and who currently 
smokes cigarettes  
• OR  
• Former (ex-smoker) smoker: an adult who has smoked 100 or more cigarettes in their lifetime but 
has quit) 
• Smoker • 1 
• Former (Ex-smoker) • 2 
• Non-Smoker • 3 
If NON-SMOKER selected “Thank you for your response – the survey is only intended for current or former 
smokers. You will not be required to answer the rest of the survey. 
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2. How old are you? 
• Younger than 18 years • 1 
• 18-25 years • 2 
• 26-35 years • 3 
• 36-45 years • 4 
• 46-55 years • 5 
• 56-65 years • 6 
Older than 65 years • 7 
If you are younger than 18 please DO NOT answer the rest of the survey. 
 
3. Gender: 
• Male • 1 
• Female • 2 
 
4. What is your highest educational qualification? 
• Grade 11 or lower • 1 
• Grade 12 • 2 
• Post Matric Certificate or Diploma • 3 
• Bachelor’s degree(s) • 4 
• Post-Graduate Degree(s) • 5 
 
Section B – Smoking Patterns 
This section explores smoking patterns among individuals. 
 
Part B1 
5. At what age did you start smoking?  
• Before 10 years • 1 
• 10-15 years • 2 
• 16-20 years • 3 
• 21-25 years • 4 
• 26-30 years • 5 
• 31-35 years • 6 




6. Duration of smoking: 
• 0-5 years • 1 
• 6-10 years • 2 
• 11-15 years • 3 
• 16-20 years • 4 
• 21-25 years • 5 
• More than 25 years • 6 
 
7. On average, how many cigarettes do/did you smoke daily? 
• Less than 5 • 1 
• 5-10 • 2 
• 11-15 • 3 
• 16-25 • 4 
• More than 25 • 5 
 
Part B2 
8. How aware are you of the health risks posed by cigarette smoking? 
• Not at all aware 
• 1 
• Slightly aware 
• 2 
• Somewhat aware 
• 3 
• Moderately aware 
• 4 
• Extremely aware 
• 5 
 
9. Do/did you have any ailments (conditions) you think may have been caused by smoking? 
• Yes  • 1 
• No • 2 
• Unsure • 3 
 
9.1 If yes or unsure, please describe what these are: 
•  
 
10. On average, how would you describe your nicotine (smoking) dependence? 
• For former smokers, how was your dependence when you were smoking, on average? 
• Low • 1 
• Moderate • 2 
• High • 3 
 
11. What time of day are/were your cravings worst, if any? 
• (Mark all applicable) 
• No cravings • 1 
• Morning • 2 
• Afternoon • 3 
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• Evening • 4 
• After meals • 5 
• Before meals • 6 
• Other: Please specify:  • 7 
 
12. Have you made any attempts to quit smoking? 
• Yes • 1 
• No • 2 
• Former smoker • 3 
• If YES or FORMER SMOKER, direct to Part B3. 




13. If you have made attempts to quit smoking or are a former smoker, how many attempts have you made to 
quit smoking? 
• 1-5 • 1 
• 6-10 • 2 
• 11-15 • 3 
• More than 15 • 4 
 
14. On average, were you abstinent for days, weeks, months or years?  
• Days • 1 
• Weeks • 2 
• Months • 3 
• Years • 4 
 
15. When making attempts to quit, what were your reasons for cessation? 
• To stop smoking • 1 
• To reduce the amount smoked • 2 
 
16. What were your reasons for stopping or reducing? 
• You may select multiple options. 
• For health reasons • 1 
• For loved ones • 2 
• Social pressures • 3 
• Premature aging • 4 
• Financial reasons • 5 
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• To cope better where smoking is prohibited • 6 
• Other: Please specify • 7 
 
17. Did you experience any withdrawal symptoms when you stopped?  
• No • 1 
• Yes • 2 
 
 
17.1 If yes, which of the following withdrawal symptoms did you experience? 
• You may select multiple options. 
• Cigarette cravings • 1 
• Sweating • 2 
• Anxiety • 3 
• Tingling in hands and feet • 4 
• Nausea and abdominal cramping • 5 
• Constipation and gas • 6 
• Headaches • 7 
• Sore throat • 8 
• Coughing • 9 
• Difficulty concentrating • 10 
• Insomnia • 11 
• Depression • 12 
• Irritability • 13 
• Weight gain or increased appetite • 14 
• Other: Specify • 15 
 
18. Did you ever relapse (resume smoking) once you had tried to quit? 
• Yes • 1 
• No • 2 
 
18.1 If yes, what were the possible causes of your quitting being unsuccessful? 
• You may select multiple options. 
• Associating with other smokers, especially socially • 1 
• Not getting enough sleep or rest • 2 
• Feeling overconfident • 3 
• Consuming alcohol • 4 
• Becoming isolated from friends and family • 5 
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• Frequent stressful situations or encounters • 6 
• Pessimism or a negative attitude • 7 
• Struggle to cope with various emotions • 8 
• Cigarette cravings • 9 
• Mood swings or irritability • 10 
• Weight gain or increased appetite  • 11 
• Has never relapsed • 12 
• Other: Specify  • 13 
 
 
19. If you have never made a quit attempt, what are the specific reasons why? 
• You may select multiple options. 
• Concern that withdrawal symptoms may be too strong • 1 
• Fear of weight gain • 2 
• You are surrounded by other smokers  • 3 
• You don’t see any reason to quit • 4 
• Other: Specify • 5 
 
Section C – Methods to aid in quitting smoking 
This section addresses complementary medicine use as well as other therapies or tools used by smokers or former 
smokers to aid in quitting smoking. 
 



























































• Training or exercise • 1 • 2 • 3 • 4 • 5 
• Self-help materials 
• E.g., Finding a positive hobby like reading or meditation 
• 1 • 2 • 3 • 4 • 5 
• Hypnosis • 1 • 2 • 3 • 4 • 5 
Behavioural therapy  
E.g., Social skills training, behavioural rehearsal, relaxation 
training, among others.  
• 1 • 2 • 3 • 4 • 5 
• Counselling • 1 • 2 • 3 • 4 • 5 
• Non-nicotine medications • 1 • 2 • 3 • 4 • 5 
• Willpower • 1 • 2 • 3 • 4 • 5 
• Conventional methods 
• E.g., Nicotine patches, Nicorette, Anti-depressants, GABA, NAC, 
castor oil 
• 1 • 2 • 3 • 4 • 5 
• Deep breathing • 1 • 2 • 3 • 4 • 5 
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• Meditation • 1 • 2 • 3 • 4 • 5 
• Massage therapy • 1 • 2 • 3 • 4 • 5 
• Yoga • 1 • 2 • 3 • 4 • 5 
• Combination of methods, not using any medication • 1 • 2 • 3 • 4 • 5 




21. Provide the names/descriptions of any complementary medicines (such as: herbal products or supplements) 
you can remember that you have taken at any time during your diagnosis: 
Product name: Duration/ estimate of time: 
1.  










22. The practice of complementary medicine includes many professions. Please rate in the first column how 
often you used the following complementary therapies in quitting smoking. In the second column, please rate 
how effective you found each of these therapies that were used. 
 




















and spinal column. 
















1 2 3 4 5 1 2 3 4 5 6 
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in minute doses. 
1 2 3 4 5 1 2 3 4 5 6 
Phytotherapy 
Uses extracts of 
plant origin (herbs) 
as medicines or to 
promote healing. 
1 2 3 4 5 1 2 3 4 5 6 
Traditional 
Chinese Medicine 
and Acupuncture  
includes 









usually with a 
needle penetrating 
the skin, to treat 
health conditions. 
1 2 3 4 5 1 2 3 4 5 6 
Ayurveda 
uses diet, herbal 
treatment, and 
yogic breathing to 
obtain balance. 
1 2 3 4 5 1 2 3 4 5 6 
Unani-Tibb 
uses lifestyle 
changes to treat or 
prevent diseases. 
1 2 3 4 5 1 2 3 4 5 6 
Therapeutic 
Aromatherapy 
natural and holistic 
therapy using 
essential oils to 
treat the entire 
1 2 3 4 5 1 2 3 4 5 6 
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reduces stress, and 
works on a specific 
problems like 
injuries. 








of reflex points on 
the feet and hands. 
1 2 3 4 5 1 2 3 4 5 6 
 
23. If you have never used a form of complementary medicine to aid in quitting smoking, how likely are you to 
consider it for future attempts? 
• Very unlikely • Unlikely • Neutral • Likely • Very likely 
• 1 • 2 • 3 • 4 • 5 
 
24. If you have never used Complementary Medicine to quit smoking and are not likely to consider it, why not? 
• I do not believe in or use Complementary Medicine  • 1 
• I’ve heard negative things about it • 2 
• I do not know enough about it to use it trustingly • 3 
• Other: Specify • 4 
 
25. Would you consider participating in future research regarding complementary medicine use in cigarette 
smoking cessation? 
• Yes • 1 
• No • 2 
 
ON COMPLETION OF SECTION C OR IF NO FROM PART B2 (Question 12): 
Thank you for your participation. Results will be made available to participants on request once the data has been 















































E.g. Finding a 
positive hobby 
















































































































































































































every time Every time 















































































































































Chiropractic 0 (0,0%) 1 (16,7%) 3 (50%) 0 (0,0%) 2 (33,3%) 
Naturopathy 0 (0,0%) 1 (20%) 1 (20%) 2 (40%) 1 (20%) 
Homeopathy 0 (0,0%) 0 (0,0%) 2 (28,6%) 0 (0,0%) 5 (71,4%) 
Phytotherapy 0 (0,0%) 0 (0,0%) 1 (50%) 1 (50%) 0 (0,0%) 
TCM and 
Acupuncture 
1 (50%) 0 (0,0%) 1 (50%) 0 (0,0%) 0 (0,0%) 
Acupuncture 1 (33,3%) 0 (0,0%) 0 (0,0%) 0 (0,0%) 0 (0,0%) 
Ayurveda 0 (0,0%) 1 (33,3%) 0 (0,0%) 0 (0,0%) 1 (33,3%) 
Unani-Tibb 0 (0,0%) 2 (50%) 1 (25%) 0 (0,0%) 0 (0,0%) 
Therapeutic 
aromatherapy 




0 (0,0%) 1 (50%) 0 (0,0%) 0 (0,0%) 0 (0,0%) 
Therapeutic 
reflexology 
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